{
  "block": 106139546,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "7939.713329 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2026-05-17T20:59:18",
  "trx_id": "78461502dbb16f441977f8ebe0fa7d5de684da34",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 105962358,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "5227.502924 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2026-05-11T16:40:51",
  "trx_id": "1d9240396b0a44749a378dc282cc6b5f9c9a1433",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 105507290,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "7952.229085 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2026-04-25T20:25:12",
  "trx_id": "c8dd36f5d1158f7b95220e41bd5287f78e21fc9e",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 102841347,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "5269.049743 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2026-01-22T23:03:48",
  "trx_id": "09f6765b998f62268602beb3e28d6e137d04c888",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 91287795,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "5433.268940 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2024-12-16T18:24:57",
  "trx_id": "3204fa7c2e8e3762669c84ef514178ec5ec6246d",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 79842081,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "5602.402472 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-11-13T10:11:09",
  "trx_id": "6af686eafaec028b1165d6d7b94608617027995d",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 78343234,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "8539.681258 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-09-21T17:59:06",
  "trx_id": "969941058e3321394e7f19c537e2c3d650f486b2",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 69109115,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "8761.362696 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-11-03T08:14:03",
  "trx_id": "e46a0885a79cc7d6c5bdf47009e2259de5602b62",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 60805667,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "8981.895927 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-01-17T07:48:54",
  "trx_id": "2e8770f04ccc2059465d43304bad4ee4fb8345a7",
  "trx_in_block": 54,
  "virtual_op": 0
}

{
  "block": 54604215,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "9165.664585 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2021-06-13T21:52:03",
  "trx_id": "9c2efc503579b76b462940dd0cd7cd165d258113",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 49351798,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "9353.086559 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2020-12-11T08:15:18",
  "trx_id": "97f4c7a31bd31a2e708f0e5c6c02d75eac0fcc79",
  "trx_in_block": 7,
  "virtual_op": 0
}

{
  "block": 49203367,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "1912.543513 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2020-12-06T01:52:42",
  "trx_id": "c7e0a0d3bb6be8db362608cbf5299934ddd2a5eb",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 48906491,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "9370.213176 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2020-11-25T14:47:00",
  "trx_id": "1b0e7f000a6266de54987ea5ea4a4a87ab032f1b",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 43213579,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "9562.099772 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2020-05-09T02:47:21",
  "trx_id": "30a0f5845d76b6ab28284450f1b454cfaf06b05d",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 43189142,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "1953.311140 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2020-05-08T05:56:18",
  "trx_id": "9108384504cc71732b3129692615672a0f191059",
  "trx_in_block": 13,
  "virtual_op": 0
}

{
  "block": 42798349,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "9570.475238 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2020-04-24T07:56:03",
  "trx_id": "5bc1fd8dffb8116fecab236aeee4db6d6e38de1e",
  "trx_in_block": 11,
  "virtual_op": 0
}

{
  "block": 33075294,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "9765.980965 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-05-20T14:31:45",
  "trx_id": "4f75916a2f85a8e62962d357dd55cde0b119f367",
  "trx_in_block": 21,
  "virtual_op": 0
}

{
  "block": 31787547,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "29783.975410 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-04-05T19:27:39",
  "trx_id": "6fb904fb1a6ae031363893a538198eddb4595cad",
  "trx_in_block": 4,
  "virtual_op": 0
}

{
  "block": 31715119,
  "op": [
    "comment",
    {
      "author": "steemitboard",
      "body": "Congratulations @ahila! You received a personal award!\n\n<table><tr><td>https://steemitimages.com/70x70/http://steemitboard.com/@ahila/birthday1.png</td><td>Happy Birthday! - You are on the Steem blockchain for 1 year!</td></tr></table>\n\n<sub>_You can view [your badges on your Steem Board](https://steemitboard.com/@ahila) and compare to others on the [Steem Ranking](http://steemitboard.com/ranking/index.php?name=ahila)_</sub>\n\n\n###### [Vote for @Steemitboard as a witness](https://v2.steemconnect.com/sign/account-witness-vote?witness=steemitboard&approve=1) to get one more award and increased upvotes!",
      "json_metadata": "{\"image\":[\"https://steemitboard.com/img/notify.png\"]}",
      "parent_author": "ahila",
      "parent_permlink": "hearing-protection-devices-market-or-growth-or-tends-or-forecast-2018-2024-or-pbigp",
      "permlink": "steemitboard-notify-ahila-20190403t070441000z",
      "title": ""
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-04-03T07:04:42",
  "trx_id": "7e848ae410151e09cca327f6e842c99180814e09",
  "trx_in_block": 12,
  "virtual_op": 0
}

{
  "block": 30456950,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Hearing Protection Devices Market By Product, Application, End-Users And Geographical Regions. Key Players Such As 3M, JSM, Honeywell International Inc., And Centurion Safety Products Limited. \n\nPrecision Business Insights (PBI) in its report titled “Global hearing protection devices market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 and Forecast 2018-2025” assesses the market performance over eight years forecast period over 2018-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.\nRequest Sample Report: https://bit.ly/2RghKGH\nMarket boosts and restraining factors\nU.S. Department of labour, Occupational Safety and Health Administration (OSHA) 2002, hearing conservation program designed to protect employees from significant occupational and hazardous noise exposure from hearing impairment. The construction industry, mining, aviation have a positive impact on Hearing Protection Devices Market.\nFactors such as increased awareness regarding hearing protection devices, favourable government regulations to protect employees from hazardous noise in a working environment is expected to create demand for hearing protection devices. \nRising healthcare expenditure, increased disposable income, a surge in awareness regarding the availability of Hearing Protection Devices Market are expected to accelerate the market revenue growth.\n \nAsia Pacific is expected to dominate the global Hearing Protection Devices Market\nRapid economic growth in emerging countries, such as India and China, increased awareness, improving healthcare infrastructure, favourable reimbursement policies are expected to trigger the hearing protection devices market.\nFactors such as rise in healthcare expenditure, adoption of advanced hearing protection devices witnessed to create healthy opportunities for the market players in U.S. market. \nLimited healthcare infrastructure in low-income countries, lack of reimbursements are expected to dampen the hearing protection devices market.\n \nTechnological advancements and strategic alliances are the key strategies adopted by market players\nMarket players are focused on the introduction of novel products, increase distribution, mergers and acquisitions to improve their market position in hearing protection devices market.\n\nSome of the key players’ profiles in the global hearing protection devices market include:\n•\t3M (U.S)\n•\tJSP Ltd.(UK)\n•\tHoneywell International, Inc. (U.S)\n•\tCenturion Safety Products Limited (UK)\n•\tADCO Hearing Products (U.S)\n \nDetailed segmentation \nBy Product \n•\tEar Plugs\n•\tEar Muffs\n•\tOthers\n\nBy Application\n•\tMilitary\n•\tConstruction\n•\tAviation\n•\tOthers\n\nBy Distribution Channel \n•\tHospitals\n•\tClinics\n•\tOthers\n\nBy Geography\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tAsia-Pacific\n•\tThe Middle East & Africa\n \nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-hearing-protection-devices-market/",
      "json_metadata": "{\"tags\":[\"hearing\",\"protection\",\"devices\",\"market\"],\"links\":[\"https://bit.ly/2RghKGH\",\"https://www.precisionbusinessinsights.com/market-reports/global-hearing-protection-devices-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "hearing",
      "permlink": "hearing-protection-devices-market-or-growth-or-tends-or-forecast-2018-2024-or-pbigp",
      "title": "Hearing Protection Devices Market  | Growth | Tends   | Forecast 2018 - 2024 | PBIGP"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-02-18T13:53:48",
  "trx_id": "34b90e89b0c7fee680906104a06811c5de5d8a4c",
  "trx_in_block": 17,
  "virtual_op": 0
}

{
  "block": 30456734,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "The Future Insights Of Global Acute Conjunctivitis Treatment Market\nConjunctivitis, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Conjunctivitis can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but treatment can speed up the recovery process. Allergic conjunctivitis can be treated with antihistamines. Bacterial conjunctivitis can be treated with antibiotic eye drops.\nAcute conjunctivitis treatment market is growing due to increase of aging population, increase in ophthalmic diseases prevalence rate, rise in investments for the development of new products, growing conscious towards health, funded eye check-up campaigns by governments of different countries are driving the growth of allergic conjunctivitis treatment market. Moreover, increasing awareness about various eye infections and rise in blindness prevalence among geriatric population boosting the growth of allergic conjunctivitis treatment market. However, due to the stringent regulations in drugs developmental process and side effects associated with the various antibiotics would hamper the adoption of eye infection pharmaceutical treatment, in turn, hinder the growth of bacterial conjunctivitis treatment market.\n\nRequest Sample Report: https://precisionbusinessinsights.com/request-sample?product_id=16241\n\nThe global acute conjunctivitis treatment market is categorized as- \n1.\tType of conjunctivitis\n•\tViral Conjunctivitis\n•\tBacterial Conjunctivitis\n•\tAllergic Conjunctivitis\n•\tConjunctivitis Caused by Irritants\n2.\tDosage form\n•\tGels and Cream\n•\tEye drops\n•\tTablets and Capsules\n3.\tDrug class\n•\tAntihistamines\n•\tAntibiotic\n•\tMast cell stabilizers\n•\tAnti-inflammatory drugs\n•\tOthers\n4.\tEnd-users\nHospital, retail and online pharmacies\nAnd finally on the basis of geographical regions, the global acute conjunctivitis treatment market is divided into five major regions-North America, Europe, the Middle East & Africa and Latin America.  North America is dominating global bacterial conjunctivitis treatment market owing to few factors like rising more number of approvals by FDA, various strong strategies by pharma companies, rise in R&D investments. The European market is the second largest in allergic conjunctivitis market. Increase in prevalence and growing awareness of conjunctivitis and its treatments are leading the growth of Asia Pacific allergic conjunctivitis treatment market. The Middle East and Africa allergic conjunctivitis market is expected to have limited growth because of lack of traditional healthcare practices and slow adoption of new products and therapies.\nSome of the key players in global acute conjunctivitis treatment market are Pfizer, Inc. (U.S), Allergan Inc. (Ireland), Boehringer Ingelheim GmbH (Germany), CIBA Vision Ophthalmics (U.S), Sanofi (France), Novartis AG (Switzerland), Bausch & Lomb Inc. (Valeant) (Canada), Merck & Co., Inc. (U.S), and Santen Pharmaceuticals Co. Ltd.(Japan). For e.g. in 2017, Teva Pharmaceuticals launched, generic version of Pataday (olopatadine hydrochloride ophthalmic solution) 0.2%, in U.S used to treat Allergic conjunctivitis. \nAs per the clinical study conducted by scientists Neal P. Barney and Amir A. Azari in 2013, which was published in Journal of American Medical Association (JAMA), states that bacterial conjunctivitis accounts for about 50% of conjunctivitis cases in U.S.  and also estimated that the bacterial conjunctivitis incidence rate was anticipated as 135 in 10,000.Top pharma companies are dominating the market owing to different factors like sale, strong global presence, and efficient distribution network, R&D investments, products of superior quality, and strong brand image. In 2016, Irish based pharma company Shire’s Xiidra received U.S.FDA approval which is used to treat dry-eye. \n\nFor More Information: https://precisionbusinessinsights.com/market-reports/global-acute-conjunctivitis-treatment-market/",
      "json_metadata": "{\"tags\":[\"acute\",\"conjunctivitis\",\"treatment\",\"market\"],\"links\":[\"https://precisionbusinessinsights.com/request-sample?product_id=16241\",\"https://precisionbusinessinsights.com/market-reports/global-acute-conjunctivitis-treatment-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "acute",
      "permlink": "acute-conjunctivitis-treatment-market-or-bacterial-conjunctivitis-or-pbigp",
      "title": "Acute Conjunctivitis Treatment Market | Bacterial conjunctivitis | PBIGP"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-02-18T13:43:00",
  "trx_id": "235251fef8c136501cd7823ef3a105108fab223d",
  "trx_in_block": 22,
  "virtual_op": 0
}

{
  "block": 30255656,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A Study On Biopharmaceutical Contract Manufacturing (BCMO) Market: \nBiopharmaceutical products are pharmaceutical drugs that are synthesized, processed, or extracted from biological sources. Biopharmaceuticals include vaccines, blood products, recombinant therapeutic proteins, allergens, gene therapies, tissues and living cells used in cell therapy. Due to lack of manufacturing capabilities and to reduce the cost of manufacturing process, many companies are outsourcing. Contract manufacturing organizations offer a wide range of services such as cell line development, process optimization, fermentation biotechnology, analytical characterization, cGMP manufacturing, and validation in each stage of clinical development and commercialization.\n\nRequest Sample Report :https://precisionbusinessinsights.com/request-sample?product_id=15549\n\nBiopharmaceutical contract manufacturing (BCMO) market is mainly driven by increase in investment of the pharma and biotechnological companies to develop and commercialize the biotechnological products. In addition, high revenue generation of blockbuster biological drugs such as humira, rituxan, lantus, avastin, herceptin and remicade are gaining traction from many biologics manufacturers. However, high cost associated with manufacture and stringent regulatory requirements are expected to hamper the growth of biologics contract manufacturing market.\nThe global biopharmaceutical contract manufacturing market is categorized into following:\n1.\tManufacturing process\n•\tMammalian Based\n•\tMicrobial Based\n•\tInsect Based\n•\tPlant Based\n•\tYeast Based\n•\tOthers\n2.\tType of service\n•\tFormulation\n•\tFill and Finish services\n•\tCell Banking\n•\tAnalytical Services\n•\tProcess development\n•\tOthers\n3.\tMolecule type\n•\tLarge Molecules\n•\tSmall Molecules\n4.\tEnd-users\n•\tBiopharmaceutical Companies\n•\tPharmaceutical Companies\n•\tResearch Organizations\n•\tOthers\nAnd lastly, on the basis of geographical regions, the global biopharmaceutical contract manufacturing market have five major regions- North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America and Europe are front-runner in biopharmaceutical contract manufacturing (BCMO) market owing to increased approvals of biosimilars and increase in biopharmaceutical research organization. In Asia-Pacific region, emerging countries such as China and India are growing at a rapid rate owing to low cost of manufacturing. \nSome of the key players in global biopharmaceutical contract manufacturing market are Lonza Group Ltd. (Switzerland), Boehringer Ingelheim GmbH (Germany), Charles River Laboratories, Inc. (U.S), Novartis AG (Switzerland) WuXi AppTec Group (China), Rentschler Biotechnologie GmbH (Germany), Fujifilm Holdings Corporation (Japan), Celonic AG (Switzerland), BIOMEVA GmbH (Germany), and ProBioGen AG (Germany) to name a few. In 2016, Moderna Therapeutics and Charles River Laboratories International, Inc., an early-stage contract research organization (CRO), had collaborated to support Moderna’s nonclinical discovery and development efforts.\nIn biopharmaceutical contract manufacturing market, the services providers are increasing their service offerings such as formulation, production and analytical services apart from conventional services. Cost considerations and quick services are expected continue to drive the outsourcing of biologics contract manufacturing market. In 2017, Lonza Group Ltd. acquired cell and gene contract manufacturer PharmaCell B.V., this acquisition broadens Lonza’s capabilities in Europe region. Companies expanding the manufacturing facilities to increase market share. For instance, in 2017, Boehringer Ingelheim GmbH started a new manufacturing facility in China to increase their manufacturing capacity.\n\n\nFor More Information : https://precisionbusinessinsights.com/market-reports/global-biopharmaceutical-contract-manufacturing-market/",
      "json_metadata": "{\"tags\":[\"bcmo\",\"market\"],\"links\":[\"https://precisionbusinessinsights.com/request-sample?product_id=15549\",\"https://precisionbusinessinsights.com/market-reports/global-biopharmaceutical-contract-manufacturing-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "bcmo",
      "permlink": "biopharmaceutical-contract-manufacturing-bcmo-market-2018-2024-or-pbigp",
      "title": "Biopharmaceutical Contract Manufacturing (BCMO) Market 2018 – 2024 | PBIGP"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-02-11T14:00:51",
  "trx_id": "417f27226bd71325dfaa7e5059b68244dd7c37a9",
  "trx_in_block": 21,
  "virtual_op": 0
}

{
  "block": 29962859,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "oct-imaging-system-or-optical-coherence-tomography-oct-market-or-pbigp",
      "voter": "hozn4ukhlytriwc",
      "weight": 1500
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-02-01T09:47:57",
  "trx_id": "6ba34ebeb0ef84a7fa0e118257f0778055a91e14",
  "trx_in_block": 26,
  "virtual_op": 0
}

{
  "block": 29962316,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "oct-imaging-system-or-optical-coherence-tomography-oct-market-or-pbigp",
      "voter": "jemisteem",
      "weight": 500
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-02-01T09:20:42",
  "trx_id": "868fbdb7b40cdb1d0721df2edf258b71779e1522",
  "trx_in_block": 23,
  "virtual_op": 0
}

{
  "block": 29962236,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Global Optical Coherence Tomography Market is Expected to Increase around US$ XX Mn by 2024, Due to Increasing Disorders such as Glaucoma and Retinal Diseases Which Include Age-related Muscular Degeneration and Diabetic Eye\nAnalyst Speak:\n\n“The Global Optical Coherence Tomography Market is anticipated to reach about US$ XX Mn by 2024, and anticipated to expand at a CAGR over six years of forecast period 2019-2024 due to increasing diseases and disorders which include glaucoma and age-related muscular degeneration \n\nPrecision Business Insights (PBI) in its report titled “Global Optical Coherence Tomography Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2018 and Forecast 2019-2024” assesses the market performance over six years forecast period from 2019 to 2024. The report covers in-detail insights about the competitor’s overview, key findings and their key strategies also it gives a detailed outline about drivers, restraints, challenges and trends that are faced by the industry. \n\nThe global optical coherence tomography market size was accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Mn by 2024. Increased diseases and disorders of eye will create demand for optical coherence tomography market in the forecasted years.\n\nGlobal optical coherence tomography market is segmented on the basis of application, technology and device type.\n\n\n\nRequest Sample Report : https://precisionbusinessinsights.com/request-sample?product_id=20068\n\n\nSpectral Domain Optical Coherence Tomography (SDOCT) is expected to dominate the market\n\nBased on technology, spectral-domain optical coherence tomography (SD-OCT), swept-source optical coherence tomography (SS-OCT), and others. The SD-OCT segment accounted for largest revenue growth and is projected to dominate over the forecast period owing to demand for the non-radiation imaging modalities and rising awareness among the patients. However, insufficient clinical data and limited reimbursement facilities are hindering the growth of the market.\n\nOphthalmology segment dominates the revenue share\n\nThe ophthalmology segment is expected to show the significant growth due to an advancements in the technology in the ophthalmic devices and increase in the prevalence of eye diseases would enhance the growth of the ophthalmology market during the forecasted period.\n\nNorth America shares major Revenue Share for Optical Coherence Tomography Market\nPBI’s global optical coherence tomography market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to hold major share owing to high ubiquitousness of diseases and presence of leading manufacturers. Prevalence of diabetic retinopathy and other age-related macular degeneration (AMD) are likely to induce demand for the market in the coming years. Following North-America, Asia Pacific is anticipated to grow at a steady rate over the forecasted period owing to increased adoption towards OCT system for the diagnosis and increased number of market players and establishment of new manufacturing units in the Asian region.\nLaunch of new products and expansion of product portfolio are the key strategies adopted by the companies to enhance the growth of the market\nLaunch of new products are certain to get exposure owing to social media and prevalence of chronic diseases. This is evident by the launch of AngioVue by OptoVue in 2016. The trend is indicative of the pressing demand owing to launch of similar products such as AngioScan OCT by Nidek, DRI-Triton and 3D Oct-1 Maestro by Topcon. \nKey players in the optical coherence tomography market include Nidek Co., Ltd., Carl Zeiss AG, Terumo Corporation, Agfa Healthcare, Koninklijke philips N.V, Imalux Corporation, Optovue, Abbott Laboratories, Boston Scientific Corporation, Optopol Technology S.A, B. Braun Melsungen AG, Michelson Diagnostics, Heidelberg Engineering GmbH, Alcon, Novacam Technologies Inc., Topcon Corporation, Thorlabs Inc., and others.\nDetailed Segmentation\nBy Application Type\no\tOncology\no\tDermatology\no\tCardiology\no\tOphthalmology\no\tOthers  \nBy Technology Type\no\tFrequency Domain Optical Coherence Tomography (FD-OCT)\no\tTime domain Optical Coherence Tomography (TDOCT)\no\tSpatially Encoded Frequency Domain Optical Coherence Tomography\no\tSpectral Domain Optical Coherence Tomography (SDOCT)\no\tFourier Domain Optical Coherence Tomography  (FDOCT)\nBy Devices Type\no\tTable laptop OCT devices\no\tCatheter based OCT devices\no\tHand held OCT devices\no\tOther devices\nBy Device Type\no\tHospitals and clinics\no\tPhysician offices\no\tOthers\nGeography\n\no\tNorth America\n•\tU.S\n•\tCanada\no\tEurope\n•\tGermany\n•\tFrance\n•\tU.K\n•\tItaly\n•\tSpain\n•\tRussia\n•\tPoland\n•\tRest of Europe\no\tAsia-Pacific\n•\tJapan\n•\tChina\n•\tIndia\n•\tAustralia & New Zealand\n•\tRest of Asia-Pacific\no\tRest of World\n•\tBrazil\n•\tSouth Africa\n•\tSaudi Arabia\n•\tOthers\n\n\nFor More Information : https://precisionbusinessinsights.com/market-reports/optical-coherence-tomography-market/",
      "json_metadata": "{\"tags\":[\"optical\",\"coherence\",\"tomography\",\"market\"],\"links\":[\"https://precisionbusinessinsights.com/request-sample?product_id=20068\",\"https://precisionbusinessinsights.com/market-reports/optical-coherence-tomography-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "optical",
      "permlink": "oct-imaging-system-or-optical-coherence-tomography-oct-market-or-pbigp",
      "title": "OCT Imaging System |  Optical Coherence Tomography ( OCT) Market | PBIGP"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-02-01T09:16:42",
  "trx_id": "fa87c700cbeb9c4ccc63d76ec6576962d197aa6e",
  "trx_in_block": 8,
  "virtual_op": 0
}

{
  "block": 29962095,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Global Cardiac Guide Wire and Catheters Market is Expected to Increse around US$ XX Mn by 2024, Due to  Increasing Cardiovascular Disease Such as Heart Attack and Atherosclerosis\nAnalyst Speak:\n\n“The Global Cardiac Guide Wire and Catheters Market is anticipated to reach about US$ XX Mn by 2024, and anticipated to expanding at a CAGR over six years of forecast period 2019-2024” due to rise in occurrence of cardiovascular diseases and aging population.\n\nPrecision Business Insights (PBI) in its report titled “Cardiac Guide Wire Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2018 and Forecast 2019-2024” assesses the market performance over six years forecast period from 2019 to 2024. The report covers in-detail insights about the competitor’s overview, key findings and their key strategies also it gives a detailed outline about drivers, restraints, challenges and trends that are faced by the industry. \n\nThe global cardiac guide wire market size was accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Mn by 2024. Increased prevalence of cardiovascular disease such as heart attack and atherosclerosis will have a great demand for Global Cardiac Guide Wire and Catheters in the market. Moreover, advancements in technology and rise in the aging population are the factors that enhances the growth of the market over the forecasted period. However, lack of skilled healthcare professionals and the recent product recalls are restraining the growth of the market.\n\nGlobal cardiac guide wire and catheters market is segmented on the basis of tip flexibility, coating, material, and end user.\n\n\n\n\nRequest Sample Report : https://precisionbusinessinsights.com/request-sample?product_id=15638\n\nFloppy Guide Wires are expected to dominate the market\nBased on tip flexibility, Cardiac guide wires are segmented into floppy guide wires, stiff guide wires, and intermediate guide wires. Floppy guide wires are expected to dominate the market due to availability of advanced treatment option such as drug eluting balloons over the forecast periods. Stiff guide wires are projected to show the growth over the forecasted years.\nNorth America shares major revenue share for cardiac guide wire systems market\n\nPBI’s global cardiac guide wire and catheters market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to hold major share of global coronary guide wires market which is then followed by Western Europe owing to technological advancement, increasing number of market players in cardiac guide wires market and rising awareness regarding angioplasty procedures. It has been analyzed that cardiac guide wires have been widely adopted in clinical practice and is associated with improved clinical outcomes in Western Europe. Asia-Pacific market is expected to register fastest growth owing to the rise in geriatric population and increasing obesity, which ultimately gives rise to the number of patients suffering for cardiac artery diseases over the forecast period.\n\nProduct approvals and collaborations are the key strategies adopted by the market players that plays major role in the global cardiac guide wire and catheters market\n\nGlobal cardiac guide wire and catheters market further reveals that the key player’s increasingly adopting strategies such as approvals & mergers and acquisitions to improve market revenue share and gaining significant geographic presence across the region. For instance, in March 2017, U.S. Food and Drug Administration (FDA) approved Abbott’s new sensor-enabled FlexAbility ablation catheter, designed to work with EnSite Precision cardiac mapping system and MediGuide Technology to safely treat atrial flutter (condition similar to atrial fibrillation) and heart rhythm disorder. \n\nKey market players in cardiac guide wires market includes Medtronic, Boston Scientific, Abbott Laboratories, Cordis, Ovalum Ltd., JOTEC GmbH, QXMédical, LLC etc\n\nDetailed Segmentation\nBy Tip Flexibility\no\tFloppy\no\tStiff\no\tIntermediate\nBy Coating\no\tHydrophobic\no\tHydrophilic\nBy Material\no\tNitinol\no\tStainless steel\no\tHybrid\nBy End User\no\tHospitals\no\tASCs\no\tCardiac Catheterization Laboratories\nGeography\n\no\tNorth America\n•\tU.S\n•\tCanada\no\tEurope\n•\tGermany\n•\tFrance\n•\tU.K\n•\tItaly\n•\tSpain\n•\tRussia\n•\tPoland\n•\tRest of Europe\no\tAsia-Pacific\n•\tJapan\n•\tChina\n•\tIndia\n•\tAustralia & New Zealand\n•\tRest of Asia-Pacific\no\tRest of World\n•\tBrazil\n•\tSouth Africa\n•\tSaudi Arabia\n•\tOthers\n\n\n\nFor More Information : https://precisionbusinessinsights.com/market-reports/global-cardiac-guide-wire-catheters-market/",
      "json_metadata": "{\"tags\":[\"cardiac\",\"guide\",\"wire\",\"market\"],\"links\":[\"https://precisionbusinessinsights.com/request-sample?product_id=15638\",\"https://precisionbusinessinsights.com/market-reports/global-cardiac-guide-wire-catheters-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "cardiac",
      "permlink": "cardiac-guidewire-and-catheters-market-or-coronary-guidewires",
      "title": "Cardiac Guidewire and Catheters Market | Coronary Guidewires"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-02-01T09:09:39",
  "trx_id": "89314033d7d16db847364b4c302c444408d9bcdd",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 29709726,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "2018-2024-generic-drugs-market-or-trends-or-analysis-or-size",
      "voter": "hozn4ukhlytriwc",
      "weight": 1500
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-23T14:37:51",
  "trx_id": "0554df8d6624cb6333973b1aa048089b7a866009",
  "trx_in_block": 14,
  "virtual_op": 0
}

{
  "block": 29709601,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "feed-preservatives-market-or-boom-usd-4-2-bn-2025-or-cagr-9-8-or-pbigp",
      "voter": "devsup",
      "weight": 69
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-23T14:31:36",
  "trx_id": "925b1b8a6406ffeaa3daa0ee31a8159df75900de",
  "trx_in_block": 27,
  "virtual_op": 0
}

{
  "block": 29709375,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "2018-2024-generic-drugs-market-or-trends-or-analysis-or-size",
      "voter": "devsup",
      "weight": 69
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-23T14:20:15",
  "trx_id": "6d1388dc1fcde29f4991c9ed5b7926eb7f2e770b",
  "trx_in_block": 18,
  "virtual_op": 0
}

{
  "block": 29709302,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A Report On Global Feed Preservatives Current Market And Its Future Trends \n\nPreservatives are the substances used to prevent the spoilage of food products. Feed preservatives are used in micro quantities in the animal feed to increase the shelf life of feed by averting spoilage of food products. Preservatives or anti-oxidants are most commonly used additives in animal feed to circumvent the oxidization of animal fats and oils. Feed preservatives are classified into two types namely, natural feed preservatives and artificial or synthetic feed preservatives. \n\nIndustrialization of poultry sector, unpredictable crop harvesting patterns, increase in demand for safe and hygienic livestock products, and development of newer preservatives are anticipated to fuel the feed additives market. Furthermore, increase in export of food products around the world, changes in environmental conditions, and increase in awareness about the preservatives usage are expected to fuel the natural preservatives market. However, stringent regulatory guidelines, high cost of the preservatives especially natural derivatives, availability issues, and complexity in the manufacturing of synthetic preservatives are restraining the growth of global feed preservatives market.\n\nRequest Sample Report: https://bit.ly/2Cy4De2\n\n\n\nThe global feed preservatives market is divided into following categories- \n1.\tPreservative type \n•\tPropionates\n•\tSulfates\n•\tOthers\n2.\tApplication \n•\tFeed acidifiers\n•\tFeed antioxidants\n•\tMold inhibitors\n•\tAnticaking agents\n•\tOthers\n3.\tSource \n•\tNatural feed preservatives\n•\tSynthetic feed preservatives\n4.\tFeed type \n•\tFeed Premix\n•\tCompound Feed\n•\tSilage\n•\tFeed meal\n•\tOthers\n5.\tLivestock \n•\tRuminants\n•\tPoultry\n•\tAquatic animals\n•\tSwine\n•\tEquine\n•\tSheep\n•\tOthers\nAnd lastly, on the basis of the geographical regions, the global feed preservatives market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America feed preservatives market holds a significant revenue share in global feed additives market owing to increase in demand for packaged and ready to eat food, rise in R&D activities for the innovation of newer preservatives, and increase in the awareness about the feed preservatives among key stakeholders. Europe feed preservatives market contributes a reasonable share to the global feed preservatives market owing to the industrialization of poultry sector, increase in the aquatic animals farming, high disposable income, an increase in the preference for quality livestock products in the region. Asia Pacific feed additives market expected to exhibit significant growth rate in global feed preservatives market due to unpredictable crop harvesting patterns, that creates a need for the feed storage, regulatory requirements for improving the feed quality, and increase in exporting of feed products might from the region.\nSome of the key players in natural preservatives market are Nutreco N.V. (Netherlands), BASF SE (Germany), Alltech, Inc. (U.S.), Kemin Industries, Inc. (U.S.),  Impextraco NV (Belgium),  Biomin Holding GmbH (Austria), Perstorp Holding AB (Sweden), Novus International, Inc. (U.S.), and Cargill, Incorporated (U.S.) to name a few. Some of the notable market developments include BASF SE and Sinopec expanded propionic acid production in China, which keeps feed grain fresh for a long time by preventing molding in 2017.\nFeed preservatives market is growing at a significant rate owing to increase in the use of preservatives in feed premixes to maintain the quality of products. However, market players are focusing on the development of newer feed preservatives which reduce the food spoilage and makes the livestock healthy and hygiene. Feed acidifiers also used as feed preservatives because these are effective against harmful bacteria. Market players are focusing to develop newer feed preservatives for increasing the shelf-life of the livestock products. Moreover, acquisitions & mergers, collaborations, product approvals, and product launchings are the strategies followed by the companies for dominating the natural preservatives market. For instance, in 2017, Perstorp Holding AB announced that formic acid is on EU register of feed additives, classified in the functional group “1n:”- hygienic condition enhancer.\n\nFor More Information: https://www.precisionbusinessinsights.com/market-reports/feed-preservatives-market/",
      "json_metadata": "{\"tags\":[\"feed\",\"preservatives\",\"market\"],\"links\":[\"https://bit.ly/2Cy4De2\",\"https://www.precisionbusinessinsights.com/market-reports/feed-preservatives-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "feed",
      "permlink": "feed-preservatives-market-or-boom-usd-4-2-bn-2025-or-cagr-9-8-or-pbigp",
      "title": "Feed Preservatives Market | Boom $ 4.2 Bn 2025 | CAGR 9.8% | PBIGP"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-23T14:16:36",
  "trx_id": "60a8254dd53dbc22970cb260ed8fc7a5fbb88e04",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 29709075,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drugs Against Branded Generic Drugs\n\nA generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.\n\nThe global generic drugs market is driven by the rise of various diseases, need for cost effective drugs for treatment, and government initiatives to increase the use of generic drugs. In addition, favorable regulatory policies, patent expiration of the branded drugs, and growth in biosimilars segment are expected to boost the generic market. However, lack of awareness about the availability of generic drugs, competition from branded generics and lack of price control are hampering the generic drugs market.\n\nRequest Sample Report: https://bit.ly/2DtwBJx\n\n\n\nThe global generic drugs market is divided into following categories- \n1.\tTherapeutic area\n•\tCardiovascular\n•\tCNS\n•\tAntibiotics\n•\tOncology\n•\tGastrointestinal\n•\tHormones\n•\tPain Management\n•\tOthers\n2.\tEnd-users\nHospital, retail, online pharmacies\nAnd lastly on the basis of geographical regions, the global generic market have five major regions- North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America generic drugs market is growing due to availability of more number of generics, increase awareness about the generic drugs and favorable regulatory policies. In Europe region, the market is growing due to increased prevalence of chronic diseases, increase in investment on biosimilars, and increase awareness about generic drugs. Asia Pacific generic drugs market is expected to be fastest growing due to increased government initiatives and increase in awareness about generic drugs. While Latin America generic drugs market is also booming due to increased awareness, increased cases of chronic diseases and demand of generic drugs. \nSome of the key market players in generic market are Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), Teva Pharmaceutical Industries, Ltd. (Israel), Dr Reddy’s Laboratories (India), Novartis AG (Sandoz International GmbH) (Switzerland), Apotex Holdings Inc. (Canada), Endo International plc (U.S.), Pfizer Inc. (U.S.), Johnson & Johnson Services Inc., (Janssen Pharmaceutica) (U.S.), Lupin Limited (India), Merck & Co, Inc. (U.S.), Mitsubishi Tanabe Pharma (Japan), Momenta Pharmaceuticals (U.S.), Nexus Pharmaceuticals (U.S.), and Novo Nordisk (Denmark) to name a few. In 2017, Nexus Pharmaceuticals got U.S. FDA approval for the first generic version of Hospira’s Isuprel, for the treatment of bradycardia, heart block.\nTo improve their market position in generic drug market companies are adopting strategies like expanding their market presence through collaboration and entering into new markets. For instance, in 2017, Medical inhaler company Vectura Group PLC collaborated with Sandoz, a division of Novartis AG, to develop a generic version of an inhaler therapy for asthma and COPD (chronic obstructive pulmonary disease). Mergers and acquisitions are key strategies adopted by various market players. For instance, in 2016, Teva Pharmaceutical Industries Ltd Acquired Allergen’s generic business Actavis Generics. \n\n\n\nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/",
      "json_metadata": "{\"tags\":[\"generic\",\"drugs\",\"market\"],\"links\":[\"https://bit.ly/2DtwBJx\",\"https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "generic",
      "permlink": "2018-2024-generic-drugs-market-or-trends-or-analysis-or-size",
      "title": "2018 -2024 Generic Drugs Market | Trends | Analysis | Size"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-23T14:05:15",
  "trx_id": "75edcd66e2458c8c9b3af8ac95e42170dedebb3b",
  "trx_in_block": 4,
  "virtual_op": 0
}

{
  "block": 29708899,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Global Study On Sleep Apnea Devices Market Share, Trends And Analysis \n\nChanging aspects of sleep apnea devices market \n\nFactors responsible for growth of sleep apnea devices market include \n•\tSpeedy growth due to increasing older population joined with increased obesity levels with increasing cases of sleep apnea. \n•\tAccording to WHO, between 2015 to 2030, the number of people who will cross age 60 years will grow approximately to 56%. Based on a study, the incidences of OSA range from 3% to7% in adult men while in women is to 2% to 5%. It is also said that more than 80% of patients remains undiagnosed.\n\nRequest Sample Report: https://bit.ly/2U8IgTA\n\n\nRegional analysis:\nNorth America holds the strongest position in global sleep apnea devices market due to largest share from U.S. owing to large number of patient pool and promising reimbursement policies. \nWhile the European market is driven by government initiatives which increase awareness about sleep apnea and adoption of novel treatment options able to create lucrative opportunities \nAsia-Pacific offers profitable prospects owing to increased medical tourism in the developing countries such as South Korea, China, and India. Adoption of state-of-art technologies together with cost-effective treatments unlocks the potential of global sleep apnea devices market.\n\nMarket summary:\nThe key strategies adopted by the market players are mergers, acquisitions, collaborations, new product launches, etc. to gain market presence in the regions. For instance, Philips Respironics launched a new Dream family solution which had innovative mask design which helps OSA patients to feel comfortable while resting and experience an improved performance of sleep therapy in 2015. \n\nNotable market development:\nFisher & Paykel Healthcare launched ‘F&P Brevida nasal pillow mask for the OSA treatment in 2016. This product will be initially available only in New Zealand and Australia followed by Europe and Canada. \n \nSome of the key players in the global sleep apnea devices market are \n•\tSomnoMed Ltd.\n•\tResMed, Inc\n•\tPhilips Healthcare\n•\tFisher & Paykel Healthcare Ltd.\n•\tCompumedics Limited\n•\tBraebon Medical Corporation\n•\tWeinmann Medical Devices GmbH\n•\tBMC Medical Co., Ltd. \n•\tDeVilbiss Healthcare. \n\nThe global sleep apnea devices market is divided into following categories- \nBy Diagnostic Devices \n•\tPolysomnography Devices (PSG)\n•\tPulse Oximeters and Actigraphy Devices.\nBy Therapeutic Devices \n•\tPositive Airway Pressure (PAP) Devices\n•\tOxygen Devices\n•\tOral Appliances \n•\tAdaptive Servo Ventilation (ASV) Devices\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tThe Middle East & Africa\n•\tAsia-Pacific\n \n\nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-sleep-apnea-devices-market/",
      "json_metadata": "{\"tags\":[\"sleep\",\"apnea\",\"devices\",\"market\"],\"links\":[\"https://bit.ly/2U8IgTA\",\"https://www.precisionbusinessinsights.com/market-reports/global-sleep-apnea-devices-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "sleep",
      "permlink": "sleep-apnea-devices-market-or-type-or-size-or-forecast-2018-2024",
      "title": "Sleep Apnea Devices Market | Type | Size | Forecast 2018 - 2024"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-23T13:56:27",
  "trx_id": "8a05dd31d7f074d0edb4d02fa582a8f01144d3b9",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 29562401,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A Global Study On Biopsy Devices Market With Industrial Insights And Market Analysis\n\nA biopsy is a surgical procedure to remove the tissue from the body. It tissue sample is used for determination of signs and symptoms of cancer or inflammatory conditions. A biopsy is carried out for majority of organs in the body with specific biopsy devices. It is carried by surgeons, radiologists and interventional cardiologists to confirm the presence of disease. The different types of biopsy devices include skin biopsy, fine needle aspiration, excision and biopsy, shave biopsy, and vacuum-assisted biopsy among others. \n\nRequest Sample Report: https://bit.ly/2RUeiVK\n\nFactors such as increased cases of various cancer diseases such as prostate, breast, and lung cancers, technological development, increased adoption of integrated biopsy technologies, rise in global geriatric population, increase in the preference for minimally invasive procedures, and growing importance of disease screening for early treatment expected to propel the global biopsy devices market. However, a high cost of the biopsy devices, unfavorable reimbursement policies, stringent regulatory guidelines, and lack of skilled technicians might hamper the growth of prostate biopsy devices market. \nThe global Biopsy devices market is divided into following categories-\n1.\tDevice type\n•\tCore biopsy devices\no\tCore biopsy needles\no\tCore biopsy guns\n•\tNeedle-based biopsy devices\n•\tVacuum-assisted biopsy devices\no\tNeedles\no\tGuns\n•\tAspiration biopsy needles\n•\tOthers\n2.\tApplications\n•\tGastrointestinal biopsy\n•\tLung\n•\tLiver\n•\tBreast biopsy\n•\tGynecological\n•\tKidney\n•\tOthers\n3.\tImaging technologies \n•\tUltrasound-guided biopsy\n•\tStereotactic guided biopsy\n•\tCT scan\n•\tMRI guided biopsy\n•\tOthers\n4.\tEnd-users \nHospitals, clinics and diagnostic centers. \nAnd lastly, on the basis of geographical regions, the global biopsy devices market have five major regions- Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. North American biopsy devices market is attributed to grow due to increase in R&D activities, increase in the prevalence of cancer disease, and availability of skilled professionals are fueling the prostate biopsy devices market and breast biopsy devices market. Europe holds a major share owing to increase in the prevalence of cancer, rise in the healthcare expenditure, and rise in adoption of minimally invasive procedures are anticipated to drive the needle-based biopsy devices market. Asia Pacific region is expected to exhibit significant growth due to increase in the geriatric population especially in Japan, China, and India, increase in the prevalence of various types of cancers, and rise in the medical tourism. \nSome of the players in global biopsy devices market are Becton, Dickinson and Company (U.S.), Argon Medical Devices (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Olympus Corporation (Japan), Hologic, Inc. (U.S.), SmartTarget Ltd. (U.K.), MDxHealth (Belgium), and Intact Medical Corporation (U.S.) to name a few. Some of the market innovations in breast biopsy devices market include Hologic launched Bravera a breast biopsy system used for real-time breast biopsy and verification in 2017. \nTechnological advancements of biopsy devices and increase in the demand for biopsy devices in disease screening for early treatment propel the biopsy devices market. Acquisitions and mergers, collaborations, product and patent approvals, and product launches are key strategies followed by the players for increasing market revenue growth. For instance, in 2014, Argon Medical Devices, Inc. acquired Promex Technologies, LLC for diversification of business segment into the soft-tissue biopsy devices. \n\n\nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-biopsy-devices-market/",
      "json_metadata": "{\"tags\":[\"biopsy\",\"devices\",\"market\"],\"links\":[\"https://bit.ly/2RUeiVK\",\"https://www.precisionbusinessinsights.com/market-reports/global-biopsy-devices-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "biopsy",
      "permlink": "biopsy-devices-market-2018-to-boom-usd-2-98-billion-value-by-2025-at-a-cagr-of-6-70",
      "title": "Biopsy Devices Market 2018 to Boom $ 2.98 Billion Value by 2025 at a CAGR of 6.70%"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-18T11:45:00",
  "trx_id": "ce750f5a35ce47d6b2119e26fc687c9ea388e884",
  "trx_in_block": 11,
  "virtual_op": 0
}

{
  "block": 29562034,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "antivenom-market-or-share-or-analysis-2018-2024",
      "voter": "devsup",
      "weight": 69
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-18T11:26:39",
  "trx_id": "399da2ba652b0946988d8a04daf8753a8b465876",
  "trx_in_block": 13,
  "virtual_op": 0
}

{
  "block": 29561866,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A Steady Growth In Global Agriculture Biologicals Market Due To Newer Launches And Demand By The Consumers\nChanging aspects of agricultural biologicals market \nThe global agricultural biologics market is driven by following categories-\n•\tRising demand for organic food products globally\n•\tCost-effectiveness in comparison to other chemicals used for agriculture\n•\tLeading awareness about availability and use of eco-friendly products \n•\tExpensive cost of chemical fertilizers and pesticides\n•\tAdvantages of agriculture biologicals such as soil fertility improvement, easy residue management and enhancement of crop yield \nHowever, lack of awareness among the farmers and strict regulatory policies are restraining the global agricultural biologicals market.  \n\nRequest Sample Report : https://bit.ly/2sw4EdK\n \nSome of the key players in global agricultural biologicals market include-\n•\tIsagro SPA (Italy)\n•\tThe Dow Chemical Company (U.S.)\n•\tBayer AG (U.S.)\n•\tNovozymes A/S (Denmark)\n•\tValent Biosciences Corporation (Sumitomo Chemical Co., Ltd.) (Japan)\n•\tKoppert B.V. (Netherlands)\n•\tArysta Lifescience Corporation (Japan)\n•\tMarrone Bio Innovation Inc. (U.S.)\n•\tBASF SE (Germany)\n•\tCertis USA LLC (U.S.)\n\nThe global agricultural biologicals market is divided into following categories-  \nBy product \n•\tBio Pesticides\n•\tBio Stimulants\n•\tBio Fertilizers\n•\tBio Herbicides\n•\tOthers\nBy application \n•\tOilseeds and Pulses\n•\tFruits\n•\tCereals and Grains\n•\tOthers\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tAsia Pacific\n•\tEurope\n•\tThe Middle East and Africa\n\n\nFor More Information : https://www.precisionbusinessinsights.com/market-reports/agricultural-biologicals-market/",
      "json_metadata": "{\"tags\":[\"agricultural\",\"biologics\",\"market\"],\"links\":[\"https://bit.ly/2sw4EdK\",\"https://www.precisionbusinessinsights.com/market-reports/agricultural-biologicals-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "agricultural",
      "permlink": "global-agricultural-biologicals-market-or-boom-usd-14-2-bn-2025-or-cagr-12-75",
      "title": "Global Agricultural Biologicals Market | Boom $ 14.2 Bn 2025 | CAGR 12.75%"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-18T11:18:15",
  "trx_id": "4f7737e65a435fe00d234ba606480f5b94828d6c",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 29561734,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "An In-Depth Research And Development On Global Antivenom Market\n\nChanging aspects of antivenom market \nFactors which are responsible for the growth of the antivenom market include-\n•\tIncrease death numbers due to venomous bites\n•\tIncreased incidences of the venomous bites in underdeveloped countries and their regions\n•\tUpcoming government initiatives to develop antivenoms and their development from the manufacturers.\nHowever, intricacy in regulatory policies, lack of funding in antivenom development, and high cost of the product are impeding the growth of antivenom market. \n\nRequest Sample Report : https://bit.ly/2D45kPL\n\nRegional analysis:\nNorth America holds the largest share in the market due to presence of snake poison control centers, approval of antivenom products, presence of great quality healthcare facilities and increase in clinical trial rounds. \nAsia Pacific anti venom market is growing at a lucrative market growth due to rising number of snake bite cases when compared to urbanized regions.\nWhile in Africa and Asia-Pacific regions have a growing demand for antivenom.  According to WHO statistics, about 5million snake bites occurs in a year with half resulting into serious complication such as permanent disabilities and amputations, and death. \n \nMarket summary:\nMarket players are actively involved in R & D to develop antivenoms to meet the demand of the market. With newer and better antivenoms in the market, there will be steady growth. For e.g. Instituto Bioclon S.A developed Equine F(ab’)2 (clinical trials phase2) in antivenin to treat poison from scorpion sting. \nWith increasing demand for specific antivenom for different species of snakes, the market growth is inevitable. The local market players are focused on the increasing their production for antivenom such as Bharath Serum Vaccines limited and Vins Bioproducts in Asia-Pacific region. While the Middle East & African regions, South Africa will have lucrative business opportunity due to highest number of snakes in the country. \n\nSome of the key market players from Antivenom market are-\n•\tVins Bioproducts Limited (India)\n•\tBharat Serum and Vaccines Limited (India)\n•\tCSL Limited (Victoria)\n•\tRare Disease Therapeutics, Inc. (U.S.)\n•\tF. Hoffmann-La Roche AG (Switzerland),\n•\tInstituto Bioclon\n•\tS.A. de C.V.(Mexico)\n•\tIncepta Vaccine Ltd. (Bangladesh)\n•\tBTG Plc (U.K)\n•\tMerck & Co., Inc. (U.S)\n•\tPfizer Inc. (U.S.)\n\nNotable market development:\nIncepta Pharmaceuticals Limited launched their first antivenom which was made locally in 2015. \n\nThe global antivenom market is divided into following categories- \nBy product type \n•\tMonovalent\n•\tPolyvalent\nBy animal \n•\tSnake\n•\tScorpions\n•\tSpiders\n•\tOthers \nBy end-users \n•\tHospital Pharmacies\n•\tRetail Pharmacies\n•\tOthers\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tThe Middle East & Africa\n•\tAsia-Pacific\n\nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-antivenom-market/",
      "json_metadata": "{\"tags\":[\"antivenom\",\"market\"],\"links\":[\"https://bit.ly/2D45kPL\",\"https://www.precisionbusinessinsights.com/market-reports/global-antivenom-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "antivenom",
      "permlink": "antivenom-market-or-share-or-analysis-2018-2024",
      "title": "Antivenom Market | Share | Analysis 2018 -2024"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-18T11:11:39",
  "trx_id": "c4b26a0a1d557589b24d9c7240ec1f717b2aea1d",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 29552674,
  "op": [
    "comment",
    {
      "author": "partiko",
      "body": "Thank you so much for sharing this amazing post with us!\n\nHave you heard about Partiko? It’s a really convenient mobile app for Steem! With Partiko, you can easily see what’s going on in the Steem community, make posts and comments (no beneficiary cut forever!), and always stayed connected with your followers via push notification!\n\nPartiko also rewards you with Partiko Points (3000 Partiko Point bonus when you first use it!), and Partiko Points can be converted into Steem tokens. You can earn Partiko Points easily by making posts and comments using Partiko.\n\nWe also noticed that your Steem Power is low. We will be very happy to delegate 15 Steem Power to you once you have made a post using Partiko! With more Steem Power, you can make more posts and comments, and earn more rewards!\n\nIf that all sounds interesting, you can: \n\n- Download Partiko Android at [Google Play](http://bit.ly/2SRFIta)\n- Or Download Partiko iOS on the [App Store](https://apple.co/2PcXkSd)\n\nThank you so much for reading this message!",
      "json_metadata": "{\"app\":\"partiko\"}",
      "parent_author": "ahila",
      "parent_permlink": "2018-2024-global-medical-imaging-information-market-or-pbigp",
      "permlink": "partiko-re-ahila-2018-2024-global-medical-imaging-information-market-or-pbigp-20190118t033821348z",
      "title": ""
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-18T03:38:21",
  "trx_id": "ec2945ebb4106ad0fd8efdf4120f09fc45fd8fcd",
  "trx_in_block": 11,
  "virtual_op": 0
}

{
  "block": 29448729,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "pregnancy-testing-market-or-demand-analysis-or-growth-or-industry-forecast-2018-2024",
      "voter": "devsup",
      "weight": 69
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-14T12:54:45",
  "trx_id": "8fb1712c8b6bdfa44dd0c4e7b9f0aabd51bf031e",
  "trx_in_block": 21,
  "virtual_op": 0
}

{
  "block": 29448591,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A Research Report On Global Medical Imaging Information Market Comprising Of Market’s Current And Future Trends \nChanging aspects of medical imaging information market \nThe market dynamics of global medical imaging information market is based on following factors-\n•\tIncreases cases of chronic diseases which required precise diagnostic imaging procedures\n•\tDevelopment in diagnostic sector and innovative applications of medical imaging software\n•\tDemand for better treatment are boosting the market growth. \nHowever, security breaches with data storage, dearth for skilled professionals, and expensive investments impede the growth of medical imaging information market.\n\nRequest Sample Report : https://bit.ly/2ALO1iI\n\n \nMarket Summary: \nThe medical imaging information market is growing due to better treatment availability for diseases, technological advancements and increased number of diagnostic procedures. In addition to this, mergers, collaborations, acquisitions and new product launch are key strategies adopted by market players for increasing market share. For e.g. Royal Philips acquired TomTec imaging systems GmbH in 2017 to toughen its ultrasound business.\n \nRegional Analysis:  \nNorth America medical imaging information market is growing due to presence of huge number of important market players and technological advancements in the medical imaging. \nEurope medical imaging information market is growing at a significant share due to skilled professionals, acceptance of newer technologies, and collaborative strategies between the companies for development. \nAsia Pacific market is exhibiting significant growth due to increase in medical tourism in Asia Pacific region, and business expansion by market players. \n \nSome of the key players in the global medical imaging information market include:\n•\tGeneral Electric Company (U.S.)\n•\tKoninklijke Philips N.V. (Netherlands)\n•\tLexmark International Inc. (U.S.)\n•\tEsaote SpA (Italy)\n•\tSiemens AG (Germany)\n•\tCarestream Health, Inc. (U.S.)\n•\tDell Inc. (U.S.)\n•\tAgfa-Gevaert N.V. (Belgium)\n•\tToshiba Corporation (Japan)\n•\tMcKesson Corporation (U.S.)\n \nNotable market development:\nCarestream Health, Inc., brought in new medical imaging and digital X-ray detectors at Radiological Society of North America (RSNA) conference in U.S, in 2016. \n \nThe global medical imaging information market is divided into following categories-\nBy service type\n•\tHardware\n•\tSoftware\nBy application\n•\tMagnetic Resonance Imaging (MRI)\n•\tComputed Tomography (CT)\n•\tDigital Radiography\n•\tNuclear Imaging\n•\tX-ray\n•\tUltrasound\n•\tMammography\n•\tOthers\nBy deployment mode \n•\tCloud-Based\n•\tWeb-Based\n•\tOn-Premise\nBy end-users \n•\tHospitals\n•\tDiagnostic Centers\n•\tAmbulatory Surgical Centers\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tThe Middle East & Africa\n•\tAsia-Pacific \n\nFor More Information:  https://www.precisionbusinessinsights.com/market-reports/medical-imaging-information-market/",
      "json_metadata": "{\"tags\":[\"medical\",\"imaging\",\"information\",\"market\"],\"links\":[\"https://bit.ly/2ALO1iI\",\"https://www.precisionbusinessinsights.com/market-reports/medical-imaging-information-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "medical",
      "permlink": "2018-2024-global-medical-imaging-information-market-or-pbigp",
      "title": "2018 - 2024 Global Medical Imaging Information Market | PBIGP"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-14T12:47:51",
  "trx_id": "830d00c037e796a740ac8c85cc7d79cea33efe1e",
  "trx_in_block": 16,
  "virtual_op": 0
}

{
  "block": 29448430,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A Market Review On Global Pregnancy Testing Market Requirements And Consumer Demands \n\nChanging aspects of pregnancy testing Market\n\nGrowing awareness regarding the availability of pregnancy test kits and utilization of the self-detection pregnancy kits and benefits has expected to create demand for pregnancy test kits. Moreover, a rise in disposable income, increased healthcare expenditure, adoption of technological advancements to detect pregnancy are few factors enables stimulate the market.  However, price sensitivity of pregnancy detection kits is making unaffordable for the women in underdeveloped and developing regions. Lack of technical expertise in a woman is major restraints of the market.\n\nRequest Sample Report : https://bit.ly/2ObwKYn\n \nMarket analysis:\nAccording to WHO statistics, more than 40% of pregnancy cases were reported unintended in 2015. Factors which are responsible for market growth of pregnancy detection devices market are-\n•\tIncreasing numbers of unintended pregnancies\n•\tPromotional campaigns led by celebrities which influence consumers heavily\n•\tAnd with 99% accuracy rate in identifying HCG levels, the growth of pregnancy detections devices market is inevitable. \n\nRegional analysis:\nNorth America dominates the global pregnancy testing market due to high healthcare spending and awareness programs for effective usage of pregnancy test kits. \nEurope is to expand at robust growth rate due to the increasing disposable income with adaptation of digital pregnancy detection kits. \nAsia Pacific is growing at a substantial rate due to availability and affordability and adaptation of pregnancy testing kit in rural areas. \n\nMarket summary:\nThe market is heavily influenced by market manufacturers, mergers, acquisitions and collaborations which help in product launches and market expansions. \n\nNotable market development:\nAbbott laboratories’ I-STAT TOTAL HCG test for accurate detection of HCG hormone detection for pregnancy received USFDA approval in 2015. \n \nSome of the key market players in the global pregnancy testing market are \n•\tProcter & Gamble Co (U.S.).\n•\tAlere Inc. (U.S.)\n•\tChurch & Dwight (U.S.)\n•\tGermaine Laboratories (U.S.)\n•\tSPD Swiss Precision Diagnostics (Switzerland),\n•\tPiramal Enterprises (India)\n•\tAbbott Laboratories (U.S.)\n•\tDCC plc (Ireland)\n•\tCardinal Health (U.S.)\n•\tPrestige Brands Holdings (U.S.)\n•\tKent Pharmaceuticals (UK)\n•\tQuidel Corporation (U.S.).\n \nThe global pregnancy testing market is divided into following categories- \nBy product  \n•\tPregnancy rapid test kits\no\tLine indicator devices\no\tDigital devices\n•\tFertility rapid test\nBy test type  \n•\tFollicle stimulating hormone (FSH) test\n•\tHuman chorionic gonadotropin hormone blood test\n•\tUrine test\n•\tLuteinizing hormone (LH) test\nBy end-users  \n•\tHospital Pharmacies\n•\tRetail Pharmacies\n•\tOnline Pharmacies\n•\tGynecology clinics\n•\tHypermarkets or supermarkets\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tThe Middle East & Africa\n•\tAsia-Pacific\n\nFor More Information : https://www.precisionbusinessinsights.com/market-reports/global-pregnancy-testing-market/",
      "json_metadata": "{\"tags\":[\"pregnancy\",\"test\",\"market\"],\"links\":[\"https://bit.ly/2ObwKYn\",\"https://www.precisionbusinessinsights.com/market-reports/global-pregnancy-testing-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "pregnancy",
      "permlink": "pregnancy-testing-market-or-demand-analysis-or-growth-or-industry-forecast-2018-2024",
      "title": "Pregnancy Testing Market | Demand Analysis | Growth | Industry Forecast 2018 - 2024"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-14T12:39:48",
  "trx_id": "e866b75de4cf175cd6dcfeadada3c232d309ddaf",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 29448296,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A Research Report On Biostimulants Market Comprising Of Market’s Current And Future Trends\n\nChanging aspects of Biostimulants market \nThe global biostimulants market are growing at a substantial rate due to following factors-\n•\tHigh demand of food globally which requires to increase the yield per hectare too\n•\tBiostimulants usage will reduce the abiotic stress in the plants which increase biostimulants demand. \n•\tAnd with increasing favorable government aids and grants the use of biostimulants is indeed increasing the demand of biostimulants. \nHowever, high R&D cost and awareness dearth will hinder the growth of biostimulants market. \n\nRequest Sample Report : https://bit.ly/2H4FGMN\n\nMarket summary:\nSome of the key strategies adopted by the market players are agreements, collaborations, acquisitions and partnerships. Biostimulants market is highly dependent on raw crops such oilseeds, pulses and cereals which accounts for majority of cropped land for application of biostimulants. For e.g. in 2013, Becker Underwood was acquired by BASF for enhancing its crop protection business while in 2012, Agraquest was acquired by Bayer Crop science for accepting its technology for green products. \n \nRegional analysis:\nEurope holds the dominating position in the global biostimulants market owing to rapid development of advanced biostimulants in countries such as UK, Italy and France. \nAsia-Pacific region is next in line and also the fastest growing in countries such as Japan, India, China and Korea contributing the largest revenue share owing to demand for organic products and high quality of agricultural products.  \n\nSome of the key players in global biostimulants market are\n•\tNovozymes A/S (Denmark)\n•\tBASF SE (Germany)\n•\tIsagro SpA (Italy)\n•\tValagro SpA (Italy)\n•\tPlatform Specialty Products Company (U.S.)\n•\tItalpollina SpA (Italy)\n•\tSapec Group (Portugal)\n•\tBiostadt India Ltd (India)\n•\tKoppert B.V. (the Netherlands)\n•\tBiochim SpA (Italy)\n\nNotable market development:\nSyngenta and Valagro had an agreement to supply biostimulants for the seed treatment in 2017.\n\nThe global biostimulants market is divided into followed categories-  \nBy type\n•\tAcid-based\no\tAmino Acid\no\tHumic Acid\no\tFulvic Acid\n•\tExtract-based\no\tSeaweed Extracts\n•\tOthers\no\tMicrobial Soil Amendments\no\tB-Vitamins\no\tChitin & Chitosan\nBy crops\n•\tTurf and Ornamentals\n•\tRow Crops and Cereals\n•\tFruits and Vegetables\n \nBy application\n•\tSeed\n•\tFoliar\n•\tSoil\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tThe Middle East & Africa\n•\tAsia-Pacific \n\n\n\nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-biostimulants-market/",
      "json_metadata": "{\"tags\":[\"biostimulants\",\"market\"],\"links\":[\"https://bit.ly/2H4FGMN\",\"https://www.precisionbusinessinsights.com/market-reports/global-biostimulants-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "biostimulants",
      "permlink": "2018-2024-biostimulants-market-or-type-or-size-or-share-or-application",
      "title": "2018 – 2024 Biostimulants Market | Type | Size | Share | Application"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-14T12:33:06",
  "trx_id": "032bc1f523e5491d0389dff7118f6a7707792f6b",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 29363878,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A Steady Growth In Global Gene Editing Market Due To Newer Launches And Demand By The Consumers\n\nGene Editing Market 2017 to Boom $7,305.5 Million Value by 2024 at a CAGR of 14.7%\nChanging aspects of gene editing Market\nFactors which are leading the growth of gene editing market globally are-\n•\tDemand for personalized medicine\n•\tIncreased cases of cancer and other genetic disorders\n•\tIncreased companies investments in R &D\n•\tGrowth of pharmaceutical and biotechnology industries \n•\tIncreased funding with rapid advancements and various drug discovery applications. \nNonetheless, global gene editing market is hampered by strict government rules and regulations for approval, ethical issues, lack of awareness about the process and unavailability of gene editing therapeutics in the market. \n\nRequest Sample Report:  https://bit.ly/2DzbCWj\n\nMarket summary:\nGene editing market is heavily dominated by pharmaceutical and biotechnology sectors due to its drug discovery and therapeutics applications. Innovative research and development is what companies looking forward too, in addition to usage of CRISPR and ZFN. Many key market players are adopting strategies such as partnerships, collaborations, mergers and acquisitions which are driving the growth of genome editing market. An agreement was signed between Harvard (U.S), Institute of MIT and Sigma-Aldrich Corporation (U.S) to use CRISPR in 2014. \n\nRegional analysis:\nDue to strong presence of pharmaceuticals and biotechnology companies, North America dominates the gene editing market in global market. \nDeveloping global regions such as Latin America and Asia-Pacific is growing at a substantial rate in the global genome editing market due to research and development in the regions with automation in laboratories and instrumentation which is leading to expansion of leading genome editing companies. \n\nNotable market development:\nEuropean patent for Cellectis was granted the invention of genetically T-cells by adopting RNA-guided endonucleases (centromere and Promoter factor 1 (Cpf1) or CRISPR associated protein 9(Cas9)) in 2017. \n\nSome of the key players in global genome editing market- \n•\tCellectis S.A. (France)\n•\tApplied Stemcell, Inc. (U.S.)\n•\tGenscript (U.S.)\n•\tMerck KGaA (Germany)\n•\tHorizon Discovery Group plc,(U.K.)\n•\tOrigene Technologies, Inc. (U.S.)\n•\tSystem Biosciences, Inc. (U.S.)\n•\tSangamo Therapeutics, Inc.(U.S.)\n•\tThermo Fisher Scientific (U.S)\n•\tTransposagen Biopharmaceuticals, Inc.(U.S.)\n \nThe global gene editing market is divided into following categories-\nBy technology \n•\tZinc Finger Nuclease (ZFN)\n•\tClustered regularly interspaced short palindromic repeats (CRISPR)\n•\tTranscription activator-like effector nuclease (TALEN)\n•\tOthers\nBy application \n•\tCell Line Editing\n•\tTargeted gene mutation\n•\tAnimal Genome Editing\n•\tPlant Genome Editing\nBy product type \n•\tConsumables\n•\tInstruments and Software\nBy end-users \n•\tPharmaceutical companies\n•\tBiotechnology Companies\n•\tAcademics\n•\tClinical Research Organizations\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tAsia-Pacific\n•\tThe Middle East & Africa\n\nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-gene-editing-market/",
      "json_metadata": "{\"tags\":[\"gene\",\"editing\",\"market\"],\"links\":[\"https://bit.ly/2DzbCWj\",\"https://www.precisionbusinessinsights.com/market-reports/global-gene-editing-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "gene",
      "permlink": "gene-editing-market-or-usd7-305-5-million-value-by-2024-or-cagr-of-14-7",
      "title": "Gene Editing Market | $7,305.5 Million Value by 2024 | CAGR of 14.7%"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-11T14:09:18",
  "trx_id": "def1d42c5e9c4c988ee208a80c3164b8b6162aa9",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 29334101,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "medical-robots-market-or-boom-usd17-8-bn-2025-or-cagr-20-75",
      "voter": "spaminator",
      "weight": -4500
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-10T13:19:48",
  "trx_id": "efcf14a3e8230e3a0f51f94f07bbf9dc0b848922",
  "trx_in_block": 16,
  "virtual_op": 0
}

{
  "block": 29306277,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "medical-robots-market-or-boom-usd17-8-bn-2025-or-cagr-20-75",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-09T14:07:57",
  "trx_id": "5f5b42d170e47768de5ae8dc2e5a7636f7e4ac55",
  "trx_in_block": 4,
  "virtual_op": 0
}

{
  "block": 29306275,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A Market Review And Study On The Global Medical Robots Market And Its Growing Business \n\nGlobal Medical Robots Market 2018 to Boom $17.8 Billion Value by 2025 at a CAGR of 20.75% – Precision Business Insights.\n\nChanging aspects of medical robots market \n\nThe medical robots market is mainly driven by following factors such as-\n•\tAcceptable use of medical robots in various fields of neurology, interventional cardiology and orthopedic surgery\n•\tTechnical innovations and applications in medical field, promising government regulatory policies \n•\tAnd lastly, growing awareness together with upsurge in efforts to promote robotic research boost the market growth of the medical robots. \nHowever, lack of skilled technical professionals to perform surgeries and expensive cost impede the medical robots market.\nRequest Sample Report: https://bit.ly/2M4EmbG\n\nMarket summary:\nMedical robots are widely accepted in surgeries such as urological, orthopedic, neurological, gynecological and gastrointestinal diseases. Many medical device manufacturers entered into the medical robotic market by taking over the small-scale surgical robotic system manufacturers. For e.g. Smith & Nephew acquired Blue Belt technology which are known for their robotic system manufacturing for orthopedic surgeries. Many other companies focus on introducing better and advanced robotic prosthetics, orthotics and exoskeleton. The new concept in medical robotics and computer-assisted surgery is rehabilitation robotics. \n\nRegional analysis: \nNorth America holds the strongest position in global medical robots market due to increased awareness in the physicians towards use of innovative machineries creating productive opportunities for medical robots manufacturers. \nAsia-Pacific region is growing at high CAGR due to developing healthcare infrastructure in the region driving the medical robots market. In Japan, promising government initiatives such as “robot revolution realization council” provides regulatory reform and support healthcare which contribute growth for the medical robots.  \nSome of the key players in global medical robots market are \n•\tStryker Corporation (U.S.)\n•\tVecna Robotics (U.S.)\n•\tVarian Medical Systems (U.S.)\n•\tIntuitive Surgical, Inc. (U.S.)\n•\tKirbey lester (U.S.)\n•\tHocoma AG (Switzerland)\n•\tHouston Medical Robotics, Inc. (U.S.)\n•\tKinova Robotics (Canada)\n•\tIRobot Corporation (U.S.)\n•\tOtto Bock Healthcare (Germany)\n \nNotable market development:\nIntuitive Surgical Inc., da Vinci Sp surgical system got US FDA (510(k) clearance in 2014. \n\nThe medical robots market is divided into following categories- \nBy product type \n•\tInstruments and Accessories\n•\tRobotic Systems\no\tSurgical Robots\no\tRehabilitation Robots\no\tNon-invasive Radiosurgery Robots\no\tHospital Automation Robots\no\tPharmacy Automation Robots\no\tIV Robots\nBy application area\n•\tNeurology\n•\tOrthopaedic\n•\tCardiology\n•\tLaparoscopic\n•\tPharmacy\n•\tOthers \nBy technology \n•\tGesture Control\n•\tMachine Vision\n•\tSpeech/Voice Recognition\n•\tTactile Sensors\nBy end-users \n•\tHospitals\n•\tRehabilitation Centres\n•\tDiagnostic Centres\n•\tRadiological Centres\n•\tResearch Labs\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tThe Middle East & Africa\n•\tAsia-Pacific \n\nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-medical-robots-market/",
      "json_metadata": "{\"tags\":[\"medical\",\"robots\",\"market\"],\"links\":[\"https://bit.ly/2M4EmbG\",\"https://www.precisionbusinessinsights.com/market-reports/global-medical-robots-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "medical",
      "permlink": "medical-robots-market-or-boom-usd17-8-bn-2025-or-cagr-20-75",
      "title": "Medical Robots Market | Boom $17.8 Bn 2025 | CAGR 20.75%"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-09T14:07:51",
  "trx_id": "c6c96b9c17514caa52728ed9b1b3055ac1de793f",
  "trx_in_block": 41,
  "virtual_op": 0
}

{
  "block": 29247618,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "animal-feed-market-or-boom-usd96-5-bn-2025-or-cagr-4-75",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-07T13:13:30",
  "trx_id": "0f08f9786a3edb117cf88d9fedac2def6e5e0ad1",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 29247616,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "A report on global animal feed market based on application, industries and future investments \n\nGlobal Animal Feed Market 2018 to Boom $96.5 Billion Value by 2025 at a CAGR of 4.75% – Precision Business Insights.\nChanging aspects of animal feed market \nThe global animal feed market is growing due to following factors such as-\n•\tHigh concern related to outbreak of animal diseases\n•\tGrowing demand of domestic and international quick-service restaurants in emerging countries\n•\tRise in consumption of meat, dairy and poultry products due to inclination towards high protein diet have highly influenced the global animal feed market growth. \nHowever, lack of awareness and cost of products hinder the global animal feed market growth.\n\nRequest Sample Report: https://bit.ly/2sg9ETP\n\n Market summary:\nThe feed industry is the largest purchaser of soybean and corn meal. According to AFIA (American Feed Industry Association), an average of $20billion is spent on feed ingredients annually. The feed production is booming due to its extensive use in poultry, cattle, and swine and to other animals. The animal feed market is growing due to increase in awareness and key strategies adopted by the market players such as mergers, collaborations, partnerships and acquisitions, etc. there are investments and expansions happening in order to enhance the product portfolio. \n \nRegional analysis:\nDue to rapid urbanization and strong economic viewpoint, China is a major meat exporter and producer. High consumption of meat, milk and eggs which are high in protein is the accelerating the market revenue share. \nU.S. animal feed market is growing at a significant rate due to rising consumption of organic meat over processed meat. \nEmerging economies market is expected to a huge traction due to rise in per capita income along with a high population such as in India.\n \nSome of the key market players in the global animal feed market are-\n•\tEvonik Industries AG (Germany), \n•\tNovozymes (Denmark)\n•\tDSM (Netherlands)\n•\tDupont (Danisco) (U.S)\n•\tNutreco\n•\tBASF SE (Germany)\n•\tArcher Daniels Midlands (U.S)\n•\tCharoen Pokphand (Thailand)\n•\tAlltech Incorporated (U.S)\n•\tInvivo NSA (France)\n•\tCargill Incorporated (U.S) \n \nNotable market development:\nBoehringer Ingelheim Animal Health and Novozymes made a strategic collaboration in 2017, for the development and commercialization of probiotics for poultry production. \n\nThe global Animal Feed Market is divided into following categories-\nBy type of animal \n•\tPoultry\n•\tSwine\n•\tCanine\n•\tEquine\n•\tOvine\n•\tBovine\n•\tAquaculture\n \nBy type of feed\n•\tMedicated feed\no\tAntibiotics\no\tProbiotics\no\tProteins\no\tOthers\n•\tNon-medicated feed\no\tCereals\no\tFats\no\tOils\no\tOthers\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tThe Middle East & Africa\n•\tAsia-Pacific\n\nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-animal-feed-market/",
      "json_metadata": "{\"tags\":[\"animal\",\"feed\",\"market\"],\"links\":[\"https://bit.ly/2sg9ETP\",\"https://www.precisionbusinessinsights.com/market-reports/global-animal-feed-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "animal",
      "permlink": "animal-feed-market-or-boom-usd96-5-bn-2025-or-cagr-4-75",
      "title": "Animal Feed Market | Boom $96.5 Bn 2025 | CAGR 4.75%"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2019-01-07T13:13:24",
  "trx_id": "fb6b2476d0d7c3825b4772eda5d72fee79f6b3ab",
  "trx_in_block": 14,
  "virtual_op": 0
}

{
  "block": 28416832,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "ahila",
      "delegator": "steem",
      "vesting_shares": "29983.904087 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-12-09T16:22:48",
  "trx_id": "27033b19fe796772f3b9fc34eeff1353df3fe6cf",
  "trx_in_block": 7,
  "virtual_op": 0
}

{
  "block": 28235893,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "2hjeyv-global-analysis-on-chronic-idiopathic-constipation-treatment-market-based-on-current-market-trends-and-future-insights",
      "voter": "council",
      "weight": 1000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-12-03T09:31:18",
  "trx_id": "e5b7084e3b08836b4265bf502290b6eba1d49338",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 28235534,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "2hjeyv-global-analysis-on-chronic-idiopathic-constipation-treatment-market-based-on-current-market-trends-and-future-insights",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-12-03T09:13:21",
  "trx_id": "b1bb28b9fa27baa51ae8aa2e48044b5913445c08",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 28235532,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Chronic Idiopathic Constipation Treatment Market\n \n•\tThe global chronic idiopathic constipation treatment market is segmented on the basis of route of administration, drug class, distribution mode and end-users\n•\tThe report covers in-detail insights about the competitor’s overview, key findings and their key strategies\n\nChronic idiopathic constipation (CIC) is a gastrointestinal disorder which is due to difficulty in defecating. Since it is chronic the symptoms are worse which include gastric pain, bloating, abdominal discomfort, hard stool, incomplete evacuation and strain during the bowel movement. Since the cause is unclear, however it can be cause due to neurological, psychological and psychosomatic conditions. It is a major problem occurring to the adults or geriatric people. \n\nRequest Sample Report: https://bit.ly/2Q5Dogm\n\nFactors such as increased cases of chronic idiopathic constipation due to change in lifestyle and food habits, rise in awareness about the CIC treatment, increase in the demand for CIC drugs, and availability of the over-the-counter CIC drugs in the market are driving the CIC treatment market. Moreover, various pipeline drugs for the CIC treatment and frequent product approvals from various drug regulatory bodies are propelling the market. However, lack of physiological symptoms for the disease and less number of drugs available for CIC treatment are the factors anticipated to hinder the growth of CIC market. \nThe Chronic idiopathic constipation treatment market is divided into following categories-  \n1.\tDrug class \n•\tEmollients\n•\tLaxatives\n•\tBulk-forming agents\n•\tChloride channel activators\n•\tOsmotic products\n•\tOthers\n2.\tRoute of administration\n•\tOral\n•\tParenteral\n3.\tDistribution mode  \n•\tPrescription mode\n•\tOver-the-counter drugs\n4.\tEnd-users \n•\tHospital pharmacies\n•\tRetail pharmacies\n•\tOnline pharmacies\n•\tDrug Stores\nAnd lastly, on the basis of geographical regions, the global Chronic Idiopathic Constipation (CIC) treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. \nNorth America has a significant share in chronic idiopathic constipation treatment market owing to increased cases of CIC disease, change in lifestyle, recent FDA approvals for CIC treatment drugs, an increase in healthcare expenditure. \nIn Europe, increase in ageing population, rise in R&D activities for CIC treatments, availability of over-the-counter CIC drugs, an increase in per capita income might bolster the market. However, Asia-Pacific exhibiting lucrative growth owing to the rise in geriatric population, an increase in adoption of CIC treatments.\nSome of the key players in CIC treatment market are GlaxoSmithKline Plc. (U.K.), Bayer AG (Germany), Allergan Plc. (Ireland), Ironwood Pharmaceuticals, Inc. (U.S.), Astellas Pharma, Inc. (Japan), Sanofi S.A. (France), and  Pfizer, Inc. (U.S.) to name a few. Some of the market developments include Astellas Pharma, Inc. submitting the Supplemental new drug application in 2017 for Linaclotide for patients with chronic idiopathic constipation in Japan. \nAcquisitions and mergers, product approvals, and product launchings are the key strategies adopted by the companies for increasing their revenue share in the market. For e.g. in 2017, FDA approved Tulane manufactured by Synergy Pharmaceuticals used in the treatment of chronic idiopathic constipation.\n Key Questions Answered\n•\tWhat is the current and future CIC market outlook worldwide? What trends are affecting the global market?\n•\tWhat is the competitive landscape and market share of major players in the chronic idiopathic constipation globally?\n•\tWhat are the key, high growth markets that CIC manufacturers should expand into? Which market segments are growing the fastest?\n•\tWhat are the unmet needs with the chronic idiopathic constipation currently on the market? How will emerging technologies fulfil these unmet needs?\n•\tWhat is physician perception and market outlook of CIC?\n•\tWhat are the challenges and barriers that have hindered widespread adoption of chronic idiopathic constipation? \nReasons to buy chronic idiopathic constipation market Report:\n•\tGlobal, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering\n•\tSegment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail\n•\tIdentification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics\n•\tStudy of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses\n•\tA comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment\n•\tCompetitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies\n•\tExpertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market\n\n\nFor More Information : https://www.precisionbusinessinsights.com/market-reports/global-chronic-idiopathic-constipation-treatment-market/",
      "json_metadata": "{\"tags\":[\"chronic\",\"idiopathic\",\"constipation\",\"treatment\"],\"links\":[\"https://bit.ly/2Q5Dogm\",\"https://www.precisionbusinessinsights.com/market-reports/global-chronic-idiopathic-constipation-treatment-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "chronic",
      "permlink": "2hjeyv-global-analysis-on-chronic-idiopathic-constipation-treatment-market-based-on-current-market-trends-and-future-insights",
      "title": "Global Analysis On Chronic Idiopathic Constipation Treatment Market Based On Current Market Trends And Future Insights"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-12-03T09:13:15",
  "trx_id": "7c0268bbb203a0810d718b713eabf7cbe35adcd3",
  "trx_in_block": 4,
  "virtual_op": 0
}

{
  "block": 28235411,
  "op": [
    "comment",
    {
      "author": "cheetah",
      "body": "Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in:\nhttp://comunicati.netwww.comunicati.net/comunicati/aziende/editoria/506877.html",
      "json_metadata": "",
      "parent_author": "ahila",
      "parent_permlink": "recent-study-and-advances-in-antiretroviral-drugs-and-distinguishable-market-demands-globally",
      "permlink": "cheetah-re-ahilarecent-study-and-advances-in-antiretroviral-drugs-and-distinguishable-market-demands-globally",
      "title": ""
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-12-03T09:07:12",
  "trx_id": "0bea374f7700af508da7470d842404cc88237dd4",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 28235409,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "recent-study-and-advances-in-antiretroviral-drugs-and-distinguishable-market-demands-globally",
      "voter": "cheetah",
      "weight": 8
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-12-03T09:07:06",
  "trx_id": "b6533977495a06f097f96b92f9a775c2e5f57727",
  "trx_in_block": 16,
  "virtual_op": 0
}

{
  "block": 28235407,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "recent-study-and-advances-in-antiretroviral-drugs-and-distinguishable-market-demands-globally",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-12-03T09:07:00",
  "trx_id": "61b879cefbbe27e62feb2dcf6805c51b0686678f",
  "trx_in_block": 14,
  "virtual_op": 0
}

{
  "block": 28235406,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Antiretroviral Drugs Market\n\nRetroviruses are a single stranded RNA containing virus. Retrovirus use enzyme called reverse transcriptase to copy their RNA into DNA of the host cell. The retrovirus integrates its viral DNA into DNA of the host cell, which allows the retrovirus to replicate. Retroviruses can cause different outcomes for the infected cell. Retroviruses are capable of inducing autoimmune, immunosuppressive, and neurological illnesses. Some retroviruses, such as the spumaviruses and lentiviruses are capable of directly killing cells. \n\n  Request Sample Report : https://bit.ly/2relcGE\n\nAntiretroviral drugs are the drugs that acts or inhibit certain process in viral replication and inhibits further worsening of the diseases. Globally antiviral drugs market driven by increased cases of retroviral infections such as especially HIV/AIDS. The higher prevalence of HIV owing to the various factors such as lack of availability of medication for the treatment of HIV infection, promising pipeline drugs, increased funding by the government are expected to grow the antiretroviral drugs market. However, high costs of R & D and strict regulatory procedures are hindering the antiretroviral (ARV) treatment market.\n\nThe global antiretroviral drugs market is categorized as under- \n1.\tDrug class\n•\tNucleoside Reverse Transcriptase Inhibitors (NRT’s)\n•\tNon- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)\n•\tProtease Inhibitors\n•\tIntegrate Inhibitors\n•\tFusion Inhibitors\n•\tChemokine Receptor Inhibitors\n•\tOthers\n2.\tRoute of administration\n•\tOral\n•\tParenteral\n3.\tEnd-users\n•\tHospital, retail, online pharmacies and others\nAnd lastly on the basis of geographical regions, the global antiretroviral drugs market is divided into five key regions- North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa. North America antiretroviral market is driven by combination drug therapies by key players in this region. Asia Pacific antiviral drugs market expected to be fastest growing due to developing healthcare infrastructure and increased awareness by government and non-government organization for retroviral diseases especially HIV/AIDS. The Middle East and Africa region is expected to be key region owing to availability of large pool of patients with retroviral diseases. However, poor healthcare infrastructure and lack of awareness related to retroviral diseases among healthcare professionals expected to hamper market growth in this region.\n\nSome of the key players in the global antiretroviral drugs market are Abbott Laboratories (U.S.), AstraZeneca plc (U.K.), Modified Polymer Components, Inc. (Bristol-Myers-Squibb) (U.S), Gilead Sciences (U.S.), GlaxoSmithKline Plc (U.K.), and F. Hoffmann-La Roche AG (Switzerland) to name a few. In 2016, ViiV Healthcare (Pfizer and GlaxoSmithKline’s joint venture) received U.S. FDA approval to market Selzentry for the treatment of CCR5-tropic HIV-1 infection, in combination with other antiretroviral agents.\n\nMarket players are adopting strategies like mergers and acquisitions, collaboration with government and non-government organizations to educate the people and increase awareness related to retroviral diseases. Drugs such as Doravirine (Merck & Co.), Fostemsavir (Bristol-Myers Squibb), etc. are pipeline drugs which are expected to grow the Antiretroviral (ARV) treatment market to a significant rate.\n\n\nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/",
      "json_metadata": "{\"tags\":[\"antiretroviral\",\"drugs\",\"market\"],\"links\":[\"https://bit.ly/2relcGE\",\"https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "antiretroviral",
      "permlink": "recent-study-and-advances-in-antiretroviral-drugs-and-distinguishable-market-demands-globally",
      "title": "Recent Study And Advances In Antiretroviral Drugs And Distinguishable Market Demands Globally"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-12-03T09:06:57",
  "trx_id": "29ecbfc7d6a64cc3a636be64e9cd9518949f0b3e",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 28235236,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "global-industrial-statistics-of-healthcare-bpo-market",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-12-03T08:58:27",
  "trx_id": "1c467f7df6c02e3bbf3fc336a32c5d2cfc9049a7",
  "trx_in_block": 10,
  "virtual_op": 0
}

{
  "block": 28235234,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Healthcare BPO Market\nChanging aspects of global healthcare BPO market\nHealthcare BPO market is majorly driven by economical workforce, shortage of in-house trained professionals, and lack of industrial awareness. Other important factors leading to the growth of the global healthcare BPO market are\n•\tPatent expiration in pharmaceutical industries\n•\tIncrease in awareness about patient insurance\n•\tNewer and better healthcare systems\n•\tImplementation of ICD-10 codes\nAlthough above points are booming the business, factors such as data security challenges due to breach in data storage systems, huge amount of healthcare data, and decreased quality of services are hampering the BPO market growth. \nRequest Sample Report: https://bit.ly/2DRooPW\nMarket summary: \nNew business ideas, increased development of healthcare sectors and improved digital technologies in healthcare are driving the business of global healthcare BPO market. Increased health issues, rise in older population who have respiratory, cardiovascular, eye care problems, cancers, etc. are leading factors to increased workload to insurance companies in order to handle information about patients and their data. \nThe market of healthcare BPO is growing at a substantial rate due to heavy workload in the IT healthcare sectors, upgradation from ICD-9 to ICD 10 coding system which requires trained staff, more outsourcing for money, need for HR, medical coders, skilled professionals and accounting, etc. which is going to boost the market growth of healthcare BPO. \n\nRegional analysis\nNorth America holds the strongest position in the healthcare BPO market followed by Europe owing to the factors such as ongoing trends in IT healthcare, changing regulatory scenario, etc. \nAsia-Pacific is slowly developing and showing a remarkable progress in the healthcare BPO market. This is due to various factors such as increased key noted market players and increased awareness in IT healthcare with rapid development in healthcare organizations. \nNotable market development:\nWNS (Holdings) Limited, took over Health Help, in 2017 which offers management services such as specialty healthcare areas, which include oncology, cardiology, orthopedics, sleep care, radiology and pain management. \nSome of the top players operating in the healthcare BPO market\n•\tIQVIA, HCL Technologies Limited\n•\tAccenture\n•\tEli Global\n•\tIBM Corporation\n•\tGenpact Limited\n•\tParexel\n•\tSutherland\n•\tHewlett-Packard Inc.\n•\tTruven Health Analytics\n•\tUnited Health Group\n•\tCognizant, Lonza Group Ltd\n•\tAccretive Health, Inc.\n•\tTata Consultancy Services Ltd\n•\tXerox Corporation\n•\tInfosys Limited\nThe global healthcare BPO market is segmented on the basis of provider services, payer services, pharmaceutical services, end users, and geographical regions.\nBy provider services\n•\tMedical Billing\n•\tMedical Coding\n•\tMedical Transcription\n•\tFinance & Accounts\n•\tOthers\n \nBy payer services\n•\tIntegrated Front-end Services and Back-office Operations\n•\tProvider Management\n•\tClaims Management\n•\tBilling and Accounts Management\n•\tHR\n•\tAnalytics and Fraud Management\n•\tMember Management\nBy pharmaceutical service:\n•\tManufacturing\n•\tResearch and Development\n•\tNon-clinical Services\no\tSales and Marketing\no\tSupply Chain Management and Logistics\no\tOther Non-clinical Functions\n\tHR\n\tFinance and Accounts\n\tIT\nBy end-users\n•\tHospital\n•\tClinics\n•\tPublic Service\n•\tPharmaceutical Companies\n•\tOthers\nBy geographical region\n•\tNorth America\n•\tLatin America\n•\tAsia Pacific\n•\tThe Middle East and Africa\n•\tEurope\n\n\nFor More Information : https://www.precisionbusinessinsights.com/market-reports/global-healthcare-bpo-market/",
      "json_metadata": "{\"tags\":[\"healthcare\",\"bpo\",\"market\"],\"links\":[\"https://bit.ly/2DRooPW\",\"https://www.precisionbusinessinsights.com/market-reports/global-healthcare-bpo-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "healthcare",
      "permlink": "global-industrial-statistics-of-healthcare-bpo-market",
      "title": "Global Industrial Statistics Of Healthcare BPO Market"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-12-03T08:58:21",
  "trx_id": "a716f4fcc378b3172a4fb9f83b7a7dcd0f9ef4fd",
  "trx_in_block": 31,
  "virtual_op": 0
}

{
  "block": 28118348,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "an-international-infographics-on-cheese-ingredients-market-share-size-and-analytics",
      "voter": "mrfreedomninja",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T07:31:39",
  "trx_id": "3dd0af4a35881953afd4191b2576f98b3404f37d",
  "trx_in_block": 4,
  "virtual_op": 0
}

{
  "block": 28117837,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "global-opioid-induced-constipation-treatment-market-is-increasing-due-to-increased-cases-of-chronic-pains-and-use-of-opioids",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T07:06:06",
  "trx_id": "f1950380e668c4a3d08567e3091faec3f8ce6b54",
  "trx_in_block": 19,
  "virtual_op": 0
}

{
  "block": 28117835,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Global Opioid Induced Constipation Treatment Market\n\nChanging aspects of global opioid induced constipation treatment market\n\nThe ever-growing factors such as older population who used opioid for chronic pain, prolonged use, and abuse of opioids is boosting the market growth of opioid induced constipation treatment market. In addition to that, new drug launch, increasing FDA approvals and clinical trials are also helping to grow the opioid-induced constipation treatment market. \nHowever, higher cost of medications, lack of awareness, adverse effects associated with opioid induced constipation drugs can hamper the growth of global opioid induced constipation treatment market. \nRequest Sample Report : https://bit.ly/2AGAw4r\n\nMarket summary:\nSeveral global players are actively engaged in R & D to bring newer product launches in the global opioid induced constipation treatment market. Mergers, acquisitions and collaborations among various companies to commercialize the opioid induced constipation treatment market to drive the growth. Innovative product launches, new approved drugs and drugs under clinical trials are the growing factors in the growth of the opioid-induced constipation treatment market. For e.g. in march of 2015, AstraZeneca and Daiichi Sankyo co-signed a commercialization agreement for Movenpick. \nRegional analysis\nNorth America holds the strongest position in the global opioid-induced constipation treatment followed by Asia-Pacific and Europe. According to the American Society of Interventional Pain Physician, the U.S. consumed nearly 80% of global opioids. \nEuropean countries such as UK, France, Spain, Germany, etc. have great demand for opioid analgesics thus have a significant share in the global opioid-induced constipation treatment market. \nFollowed by Asia-Pacific, factors such as rising healthcare expenditures and elderly population are boosting the opioid-induced treatment market. .\nNotable market development\nFDA approved Symphonic (Naldemedine) manufactured by Purdue Pharma LP and Shionogi for the treatment of Opioid-induced constipation in March 2017.\nSome of the players in the opioid-induced constipation treatment market \n•\tGlaxoSmithKline plc (U.K.)\n•\tAstraZeneca U.K)\n•\tPfizer Inc. (U.S.)\n•\tSLA Pharma AG (U.K.)\n•\tAIKO Biotechnology, Inc. (U.S.)\n•\tCubist Pharmaceuticals (Merck & Co.) (U.S.)\n•\tTakeda Pharmaceutical Company Limited (Japan)\n•\tBoehringer Ingelheim GmbH (Germany)\n•\tBayer AG (Germany)\n•\tValeant Pharmaceuticals International Inc. (Canada)\n•\tAbbott Laboratories (U.S.)\n•\tPurdue Pharma LP (U.S.) Shionogi Inc. (U.S.)\n•\tCosmo Pharmaceuticals  N.V. (Ireland)\nThe global opioid-induced constipation treatment market is divided on the basis of drug type, formulation type, route of administration, end-users and geographical regions. \n \nBy drug type\n•\tPeripherally restricted μ-opioid receptor antagonists\n•\tNon-selective opioid antagonists\n•\tμ -opioid receptor antagonists\n•\tLocally acting chloride channel activators\n \nBy formulation type\n•\tSolids\n•\tSemi-solids\n•\tLiquids\n \nBy route of administration\n•\tOral\n•\tParenteral (Subcutaneous Injection)\n \nBy end-users \n•\tDrugstore\n•\tRetail pharmacies\n•\tHospital pharmacies\n \nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tAsia-Pacific\n•\tEurope\n•\tThe Middle East & Africa\n\n\nView Full Report : https://www.precisionbusinessinsights.com/market-reports/global-opioid-induced-constipation-treatment-market/",
      "json_metadata": "{\"tags\":[\"opioid\",\"induced\",\"constipation\",\"treatment\",\"market\"],\"links\":[\"https://bit.ly/2AGAw4r\",\"https://www.precisionbusinessinsights.com/market-reports/global-opioid-induced-constipation-treatment-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "opioid",
      "permlink": "global-opioid-induced-constipation-treatment-market-is-increasing-due-to-increased-cases-of-chronic-pains-and-use-of-opioids",
      "title": "Global Opioid Induced Constipation Treatment Market Is Increasing Due To Increased Cases Of Chronic Pains And Use Of Opioids"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T07:06:00",
  "trx_id": "593a2cea6006195cc815c9bcc0a41660bf2ebdea",
  "trx_in_block": 14,
  "virtual_op": 0
}

{
  "block": 28117736,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "a-market-study-on-gene-editing-and-cancer-therapy-techniques",
      "voter": "davidfnck",
      "weight": 3000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T07:01:03",
  "trx_id": "b218393331c8d6dbe2166c0040f5bf9efe566ae3",
  "trx_in_block": 9,
  "virtual_op": 0
}

{
  "block": 28117676,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "an-international-infographics-on-cheese-ingredients-market-share-size-and-analytics",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T06:58:03",
  "trx_id": "6fc628fce89dcff0318768143b59ad8b5b77e9b5",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 28117674,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Changing aspects of global cheese ingredients market\nThe ever growing demand of cheese and cheese related ingredients has increased the demand of cheese ingredient market. Factors such as \n•\tHigh consumption of baked goods and confectionery products\n•\tHealth related benefits of cheese \n•\tDemand of cuisines which are cheese based will fuel the growth of cheese ingredients market. \nHowever, strict rules and regulations while manufacturing cheese, ban on use of additives by US FDA, high cost production will impede the market growth of cheese ingredients. \nRequest Sample Report :https://bit.ly/2FKBFMM\nMarket summary:\nMarket players are interested in new product launches, mergers, acquisitions and collaborations in order to strengthen the market presence in cheese ingredients market. Factors such as strict rules and regulations involved in production of various types of cheese from different types of milk. Apparently around 400 cheese varieties can be produced from various types of milk. \nRegional analysis\nNorth America holds the largest share in cheese ingredients market as exporter as well as producer too. \nEurope holds the second position in the market owing to increased consumption of cheese and its products and demand of cheese in various food industries.\nWhile Asia-Pacific is growing at a greater pace due to modern lifestyle, favorable support by government, etc. are providing huge prospects for cheese manufacturers in APAC region.\nNotable market development:\nDupont Nutrition and health launched their new CHOOZIT cultures of cheese in October 2016.\n\nSome of the key players in cheese ingredients market include \n•\tKoninklijke DSM N.V. (Netherlands) \n•\tFonterra Co-operative Group (New Zealand)\n•\tChr. Hansen Holding A/S (Denmark)\n•\tArcher Daniels Midland Company (U.S.)\n•\tE. I. du Pont de Nemours and Company (U.S.)\n•\tArla Foods (Denmark)\n \nThe global cheese ingredients market is classified on the basis of type, ingredients and geographical regions.  \nBy type  \n•\tNatural\n•\tProcessed\n \nBy ingredients  \n•\tEnzymes\n•\tMilk\n•\tCultures\n•\tAdditives\n\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tAsia-Pacific\n•\tThe Middle East & Africa\nView Full Report : https://www.precisionbusinessinsights.com/market-reports/global-cheese-ingredients-market/",
      "json_metadata": "{\"tags\":[\"cheese\",\"ingredients\",\"market\"],\"links\":[\"https://bit.ly/2FKBFMM\",\"https://www.precisionbusinessinsights.com/market-reports/global-cheese-ingredients-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "cheese",
      "permlink": "an-international-infographics-on-cheese-ingredients-market-share-size-and-analytics",
      "title": "An International Infographics On Cheese Ingredients Market Share, Size And Analytics"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T06:57:57",
  "trx_id": "8019922ec1194bc637ecd8c22e25e1e2fd49549d",
  "trx_in_block": 10,
  "virtual_op": 0
}

{
  "block": 28117493,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "phototherapy-equipment-market-by-device-type-application-distribution-channels-and-geographical-regions-key-players-such-as-atom",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T06:48:54",
  "trx_id": "91da8104fdd14c6e9769c10110216912750bfad2",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 28117491,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Phototherapy Equipment Market\n\nPrecision Business Insights (PBI) in its report titled “Global phototherapy equipment market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 and Forecast 2018-2025” assesses the market performance over eight years forecast period over 2018-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.\n\nRequest Sample Report: https://bit.ly/2QttBnG\n\nMarket boosts and restraining factors\nAccording to the National Center for Biotechnology Information (NCBI), around 13 million babies are affected with jaundice all across the globe. Aspects such as increased cases of neonatal jaundice and growing number of the preterm birth are the key factors attributed for the growth of the phototherapy equipment market. The treatment of these skin disorders requires phototherapy, which is expected to boost the growth of the market. \nHowever, the high cost of the equipment may hinder the growth of the phototherapy equipment market.\nThe global phototherapy equipment market is segmented based on the device type, application, distribution channels and geographical regions. \nNorth America holds the top spot in the global phototherapy equipment market \nNorth America phototherapy equipment market to keep top spot in the global phototherapy equipment market. The rising awareness among the people regarding the modern treatment procedures for treating skin-related disorders is enhancing the growth of the phototherapy equipment market. \nFor instance, according to the American Academy of Dermatology acne is the most common skin condition in the U.S., affecting around 50 million people in the country each year. \nEurope and Asia Pacific phototherapy equipment market is expected to grow exponentially over the forecast period.\n \nSome of the players in the global phototherapy equipment market include:\n•\tAtom Medical Corporation (Japan)\n•\tNational Biological Corp. (U.S.)\n•\tSolarc Systems Inc. (Canada)\n•\tGE Healthcare (U.K.)\n•\tPhilips Lighting Holding B.V. (Netherlands\n•\tNatus Medical Incorporated (U.S.)\n•\tPhoenix Medical Systems Pvt. Ltd. (India)\n•\tHerbert Waldmann GmbH & Co. KG (Germany)\n \nDetailed segmentation \nBy device type \n•\tFluorescent Lamps\n•\tCompact Fluorescent Lamps\n•\tFiberoptic Phototherapy Equipment\n•\tLED Phototherapy Equipment\n•\tConventional Phototherapy Equipment\n\nBy application \n•\tNeonatal Jaundice\n•\tSkin Diseases\no\to Psoriasis\no\to Eczema\no\to Other skin diseases\n•\tOthers\n\nBy end-users \n•\tHospitals\n•\tClinics\n•\tOthers\n\nBy geographical regions\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tAsia-Pacific\n•\tThe Middle East & Africa\n\n\nView Full Report: https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/",
      "json_metadata": "{\"tags\":[\"phototherapy\",\"equipment\",\"market\"],\"links\":[\"https://bit.ly/2QttBnG\",\"https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "phototherapy",
      "permlink": "phototherapy-equipment-market-by-device-type-application-distribution-channels-and-geographical-regions-key-players-such-as-atom",
      "title": "Phototherapy Equipment Market By Device Type, Application, Distribution Channels And Geographical Regions. Key Players Such As Atom Medical Corporation, National Biological Corp., Solarc Systems Inc. And GE Healthcare."
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T06:48:48",
  "trx_id": "a2d81c61e1bdd52f4847e607be8f3fda1b5b777d",
  "trx_in_block": 15,
  "virtual_op": 0
}

{
  "block": 28117274,
  "op": [
    "comment",
    {
      "author": "cheetah",
      "body": "Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in:\nhttps://www.precisionbusinessinsights.com/market-reports/global-gene-editing-market/",
      "json_metadata": "",
      "parent_author": "ahila",
      "parent_permlink": "a-market-study-on-gene-editing-and-cancer-therapy-techniques",
      "permlink": "cheetah-re-ahilaa-market-study-on-gene-editing-and-cancer-therapy-techniques",
      "title": ""
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T06:37:57",
  "trx_id": "4a17397eddfdfa710ff7a4ea7583fd9180721859",
  "trx_in_block": 11,
  "virtual_op": 0
}

{
  "block": 28117273,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "a-market-study-on-gene-editing-and-cancer-therapy-techniques",
      "voter": "cheetah",
      "weight": 8
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T06:37:54",
  "trx_id": "237f768cabd152326f81860e9c6d18118c099e51",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 28117270,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "a-market-study-on-gene-editing-and-cancer-therapy-techniques",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T06:37:45",
  "trx_id": "7ad4916c91da27bf91f42c3e54d3474f01f35532",
  "trx_in_block": 4,
  "virtual_op": 0
}

{
  "block": 28117268,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Global Gene editing Market\n\nGene editing or Genome editing is the type of genetic editing where DNA is inserted, replaced or deleted in the genome of an organism in order to treat a specific disease by using a molecular scissors or engineered nuclease. These nucleases create site-specific double-stranded breaks in desired locations in genome. The induced double-stranded breaks are repaired through non-homologous end joining or homologous recombination resulting in targeted mutations (edits).\n\nRequest Sample Report: https://bit.ly/2DzbCWj\n\nRise in the prevalence in rate of cancer & other genetic disorders, increasing preference in the personalized medicine, companies investments towards R&D, increase in private and public sector funding, rapid advancements in sequencing and gene editing technologies, applications in various drug discovery processes are some of the factors propelling the growth of the genome editing market. However, global gene editing market is hindered by stringent government regulations to approve gene mutation projects, ethical issues, lack of awareness regarding safety of genetic interventions and unavailability of gene editing based therapeutics in the gene therapy cancer market. The global gene editing market is categorized on the following topics- \n1.\tTechnology \n•\tZinc Finger Nuclease (ZFN)\n•\tClustered regularly interspaced short palindromic repeats (CRISPR)\n•\tTranscription activator-like effector nuclease (TALEN)\n•\tOthers\n2.\tApplications\n•\tCell Line Editing\n•\tTargeted gene mutation\n•\tAnimal Genome Editing\n•\tPlant Genome Editing\n3.\tProduct type\n•\tConsumables\n•\tInstruments and Software\n4.\tEnd-users\n•\tPharmaceutical companies\n•\tBiotechnology Companies\n•\tAcademics\n•\tClinical Research Organizations\nAnd lastly on the basis of geographical regions, the genome editing market is divided into five major regions- Europe, North America, Latin America, Asia Pacific, and the Middle East & Africa. North America dominates the gene editing market due to the strong growth trend in the pharmaceuticals and biotechnology industries. Emerging economies of Asia Pacific and Latin America are expected to show significant growth in the gene therapy cancer market. This is due to an increase in the number of laboratories in these regions and development of existing ones for automation of various instrumentation systems, the expansion of leading genome editing companies and increased R&D spending.\n\nSome of the key players in genome editing market are Cellectis S.A. (France), Applied Stemcell, Inc. (U.S.), Genscript (U.S.), Merck KGaA (Germany), Horizon Discovery Group plc,(U.K.), Origene Technologies, Inc. (U.S.), Sangamo Therapeutics, Inc.(U.S.), Thermo Fisher Scientific (U.S), and Transposagen Biopharmaceuticals, Inc.(U.S.) are some names. In 2017, Cellectis was granted the European Patent for the invention of the genetically engineering T-cells by adopting RNA-guided endonucleases, such as CRISPR associated protein 9 (Cas9) or Centromere and Promoter Factor 1(Cpf1 ). And in 2016, OriGene Technologies entered strategic agreement with EdiGene (Beijing, China) for the development of genome-wide knockout cells from laboratory cell lines.\nBiotechnology and pharmaceutical sectors dominate gene therapy cancer market due to its applications in drug discovery and therapeutics. Many players are adopting various strategies which include collaborations for R&D outsourcing, mergers and acquisitions, strategic or manufacturing activities are propelling the growth of global gene editing market. For example, in 2014, Sigma-Aldrich Corporation (U.S.) entered into an agreement with Broad Institute of MIT and Harvard (U.S.) to use CRISPR technology. High growth potential in emerging regions provides lucrative opportunities to industry players.\n\nView Full Report: https://www.precisionbusinessinsights.com/market-reports/global-gene-editing-market/",
      "json_metadata": "{\"tags\":[\"gene\",\"editing\",\"market\"],\"links\":[\"https://bit.ly/2DzbCWj\",\"https://www.precisionbusinessinsights.com/market-reports/global-gene-editing-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "gene",
      "permlink": "a-market-study-on-gene-editing-and-cancer-therapy-techniques",
      "title": "A Market Study On Gene Editing And Cancer Therapy Techniques"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-29T06:37:39",
  "trx_id": "2f1c7c29610e82989c3b1ac099689e6df204acfb",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 28039195,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "hearing-protection-devices-market-by-product-application-end-users-and-geographical-regions",
      "voter": "magpielover",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-26T13:32:30",
  "trx_id": "357f4204f1e2d13f07cc012b0910bec1491375bf",
  "trx_in_block": 17,
  "virtual_op": 0
}

{
  "block": 28038576,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "hearing-protection-devices-market-by-product-application-end-users-and-geographical-regions",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-26T13:01:33",
  "trx_id": "9cf2e179b40c4c24f451d1d6f22758a96940b252",
  "trx_in_block": 6,
  "virtual_op": 0
}

{
  "block": 28038573,
  "op": [
    "comment",
    {
      "author": "ahila",
      "body": "Hearing protection devices market by product, application, end-users and geographical regions. Key players such as 3M, JSM, Honeywell international Inc., and centurion safety products limited. \n\nPrecision Business Insights (PBI) in its report titled “Global hearing protection devices market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 and Forecast 2018-2025” assesses the market performance over eight years forecast period over 2018-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.\nRequest Sample Report: https://bit.ly/2RghKGH\nMarket boosts and restraining factors\nU.S. Department of labour, Occupational Safety and Health Administration (OSHA) 2002, hearing conservation program designed to protect employees from significant occupational and hazardous noise exposure from hearing impairment. The construction industry, mining, aviation have a positive impact on Hearing Protection Devices Market.\nFactors such as increased awareness regarding hearing protection devices, favourable government regulations to protect employees from hazardous noise in a working environment is expected to create demand for hearing protection devices. \nRising healthcare expenditure, increased disposable income, a surge in awareness regarding the availability of Hearing Protection Devices Market are expected to accelerate the market revenue growth.\n \nAsia Pacific is expected to dominate the global Hearing Protection Devices Market\nRapid economic growth in emerging countries, such as India and China, increased awareness, improving healthcare infrastructure, favourable reimbursement policies are expected to trigger the hearing protection devices market.\nFactors such as rise in healthcare expenditure, adoption of advanced hearing protection devices witnessed to create healthy opportunities for the market players in U.S. market. \nLimited healthcare infrastructure in low-income countries, lack of reimbursements are expected to dampen the hearing protection devices market.\n \nTechnological advancements and strategic alliances are the key strategies adopted by market players\nMarket players are focused on the introduction of novel products, increase distribution, mergers and acquisitions to improve their market position in hearing protection devices market.\n\nSome of the key players’ profiles in the global hearing protection devices market include:\n•\t3M (U.S)\n•\tJSP Ltd.(UK)\n•\tHoneywell International, Inc. (U.S)\n•\tCenturion Safety Products Limited (UK)\n•\tADCO Hearing Products (U.S)\n \nDetailed segmentation \nBy Product \n•\tEar Plugs\n•\tEar Muffs\n•\tOthers\n\nBy Application\n•\tMilitary\n•\tConstruction\n•\tAviation\n•\tOthers\n\nBy Distribution Channel \n•\tHospitals\n•\tClinics\n•\tOthers\n\nBy Geography\n•\tNorth America\n•\tLatin America\n•\tEurope\n•\tAsia-Pacific\n•\tThe Middle East & Africa\n \nFor More Information: https://www.precisionbusinessinsights.com/market-reports/global-hearing-protection-devices-market/",
      "json_metadata": "{\"tags\":[\"hearing\",\"protection\",\"devices\",\"market\"],\"links\":[\"https://bit.ly/2RghKGH\",\"https://www.precisionbusinessinsights.com/market-reports/global-hearing-protection-devices-market/\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "hearing",
      "permlink": "hearing-protection-devices-market-by-product-application-end-users-and-geographical-regions",
      "title": "Hearing protection devices market by product, application, end-users and geographical regions."
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-26T13:01:24",
  "trx_id": "817bc6668ab17feab083686b7e5321a59a455700",
  "trx_in_block": 12,
  "virtual_op": 0
}

{
  "block": 27952459,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "global-psoriasis-treatment-market-poised-to-reach-ususd-20-388-2-mn-by-2023-with-a-significant-cagr-over-the-forecast-period",
      "voter": "council",
      "weight": 1000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-23T13:12:30",
  "trx_id": "c4d68be71b6ce2f014385e40109d3b937a37e92e",
  "trx_in_block": 6,
  "virtual_op": 0
}

{
  "block": 27952243,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "global-psoriasis-treatment-market-poised-to-reach-ususd-20-388-2-mn-by-2023-with-a-significant-cagr-over-the-forecast-period",
      "voter": "davidfnck",
      "weight": 3000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-23T13:01:42",
  "trx_id": "2e4dc9ad023e384bff060d8e2953335a8a82c838",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 27951718,
  "op": [
    "vote",
    {
      "author": "ahila",
      "permlink": "global-psoriasis-treatment-market-poised-to-reach-ususd-20-388-2-mn-by-2023-with-a-significant-cagr-over-the-forecast-period",
      "voter": "mack-bot",
      "weight": -50
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2018-11-23T12:35:27",
  "trx_id": "ecb52dce5ff1234010496d1d6ec606521263c357",
  "trx_in_block": 2,
  "virtual_op": 0
}